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ABSTRACT 
 
Stem cells are unique cells that possess the capacities to both self-renew and give rise to 
multiple differentiated progeny. There exist two major types of stem cells that help to create the 
nervous system: CNS stem cells which produce the neurons and glia of the central nervous system and 
neural crest cells which produce not only the neurons and glia of the peripheral nervous system, but 
also structures such as the craniofacial skeleton, cardiac outflow tracts, skin pigment cells, and 
sympathoadrenal cells. The mechanisms of self-renewal, migration, and differentiation of these two 
stem cell types have been studied in great detail. Yet despite such insight, much remains to be known 
about key aspects of neural stem cell development. First, it has long been thought that there might be a 
lineal relationship between CNS stem cells in human embryos or adults and primary brain tumors, 
particularly those malignancies occurring in children. To earn better insight into this possibility, I 
examined fresh pediatric brain tumors and found that they contained a subpopulation of cells with 
characteristics of neural stem cells that, at a clonal level, could recapitulate properties of the parental 
tumor. These tumor-derived progenitors shared genetic similarities with normal neural stem cells and 
could migrate and proliferate in vivo. Second, I have studied whether the late-migrating wave of 
neural crest cells and their derivatives originates from stem or progenitor cells resident in the 
embryonic spinal cord by culturing quail neural tube cells as neurospheres. I have found that these 
cells have the potential to generate melanocytes and possibly other neural crest derivatives both in 
vivo and in vitro after weeks in culture, suggesting that neural crest or melanocytic progenitor cells in 
the neural tubes of older embryos might contribute to the late-migrating neural crest populations. 
Taken together, my results in both model systems suggest that neural stem or progenitor cells that 
persist in the animal beyond early embryonic development play significant roles at later points in 
development and life, particularly in the continued development of the peripheral nervous system and 
the development of malignancies of the central nervous system.  
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1.1 INTRODUCTION 
 
 The peripheral nervous system (PNS) is comprised of groups of neurons and 
support cells whose cell bodies lie outside the spinal cord and brain. These peripheral 
ganglia relay sensory input back to the central nervous system (CNS), where the 
information is processed and physical responses are generated. The PNS is primarily 
derived from a population of precursor cells called neural crest cells that arise within the 
developing CNS but subsequently migrate to the periphery and are highly versatile with 
respect to the types of derivatives that they form.  
The neural crest is one of the defining features of vertebrates. Neural crest cells 
originate in the ectoderm of the early embryo and develop as a ridge of cells flanking the 
rostrocaudal length of the open neural tube (Fig. 1), resembling a “crest.” Initially, these 
cells appear to be multipotent and subsequently give rise to both neuronal and 
nonneuronal derivatives, including neurons and support cells of the PNS, pigment cells, 
smooth muscle cells, and cartilage and bone of the face and skull (Hall, 1998; Le 
Douarin, 1982). Different populations of neural crest cells arise at different rostrocaudal 
levels of the neural axis.  For example, at cranial levels, neural crest cells contribute to 
cranial sensory ganglia as well as skeletal elements of the face.  In contrast, trunk neural 
crest cells never contribute to the bone or cartilage, but are the exclusive source of the 
peripheral ganglia and also contribute to the adrenal medulla (Fig. 2).  Thus, neural crest 
cells at all axial levels appear to have multiple developmental potentials, but they differ 
from each other according to their level of origin.  Recently, it has been shown that some 
neural crest cells are stem cells that self-renew in vivo and can contribute to at least some 
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of the derivatives generated by the neural crest (Morrison et al., 1999).  
 Interest in the mechanisms of induction, migration, and differentiation of neural 
crest cells has occupied developmental biologists for more than 130 years (Harrison, 
1938; His, 1868; Hörstadius, 1950; Landacre, 1921; Stone, 1922), reprinted in (Hall and 
Hörstadius, 1988). Much is known about the later steps of neural crest development such 
as migration pathways and cell fate decisions (Bronner-Fraser, 1993; Dickinson et al., 
1995; Erickson and Perris, 1993; Le Douarin, 1982; Stemple and Anderson, 1993). 
However, molecular aspects of these processes have only begun to be uncovered within 
the last two decades. This review summarizes recent findings regarding neural crest 
induction and the isolation and characterization of neural crest stem cells and discusses 
the involvement of neural and neural crest stem cells in the development of tumors of the 
central and peripheral nervous systems.  
 
1.2 ORIGIN AND INDUCTION OF THE NEURAL CREST 
1.2.1 Neural Crest Origin 
 
 The ectoderm is the source of the tissues that eventually form the epidermis, CNS, 
and PNS of all vertebrates. It is initially patterned into neural and nonneural ectoderm by 
signals emanating from a mesodermal organizing center during gastrulation, i.e., the 
dorsal lip of the blastopore (Spemann’s organizer) in amphibians, Hensen’s node in 
avians, the node in the mouse, and the embryonic shield in zebrafish. This process is 
called neural induction (Chang and Hemmati-Brivanlou, 1998; Sasai and De Robertis, 
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1997; Weinstein and Hemmati-Brivanlou, 1997; Wilson and Hemmati-Brivanlou, 1997). 
Later, the underlying mesoderm also plays a role in supplying rostrocaudal positional 
information to the neural ectoderm. At the start of neural induction, a broad domain of 
ectoderm adjacent to the midline thickens to form a columnar epithelium called the 
neural plate. The ectoderm outside of the neural plate will give rise to the epidermis and, 
in the head region, placodes. Placodes are regional thickenings of the ectoderm that will 
contribute to the cranial sensory ganglia and the sense organs of the head such as the 
eyes, ears, and nose (Barbu et al., 1986; Webb and Noden, 1993).  They form the 
remainder of the PNS that is not generated by the neural crest.  
 Induction of the neural crest occurs at the border region between the future 
epidermis and the neural plate (reviewed in refs. (Baker and Bronner-Frase, 1997) and 
(LaBonne and Bronner-Fraser, 1999)). As development proceeds, the neural plate begins 
to roll into a tube, causing its lateral edges to form folds that eventually approximate at 
the dorsal midline of the embryo. The neural folds typically contain the premigratory 
neural crest cells, although there are some exceptions. For example, in the frog, Xenopus, 
the cranial neural crest is not incorporated into the neural tube, but remains as a separate 
condensed mass of cells in the border region. Thus, neural crest cells delaminate from the 
neuroepithelium and begin to migrate before neural tube closure in some species (e.g., 
mouse, Xenopus) (Bartelmez, 1922; Hall and Hörstadius, 1988; Holmdahl, 1928; 
Nichols, 1981; Olsson and Hanken, 1996; Verwoerd and van Oostrom, 1979), whereas in 
other species (e.g., chicken), they migrate only after apposition of the neural folds 
(Bronner-Fraser, 1986). Thus, the CNS is formed from the rolled-up neural plate, and the 
PNS is formed from the ectodermal placodes and the neural crest cells residing in and 
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around the dorsal neural tube, which delaminate from the neural epithelium and migrate 
throughout the embryo (Fig. 1).  
 It was originally thought that the neural crest was a segregated population of cells, 
largely based on the fact that these cells appear morphologically distinct from neural tube 
cells in some species (e.g., axolotl and zebrafish). In other species, however, presumptive 
neural crest cells are not readily distinguishable from dorsal neural tube cells. Moreover, 
single-cell lineage analyses of the dorsal neural tube have shown that individual 
precursors in the neural tube can form both neural crest and neural tube derivatives in 
chick (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and Fraser, 1989), frog (Collazo 
et al., 1993), and mouse (Serbedzija et al., 1992; Serbedzija et al., 1994). Even more 
strikingly, prior to neural tube closure, the neural folds can give rise to all three 
ectodermal derviatives: epidermis, neural tube, and neural crest (Dickinson et al., 1995). 
Recently, genetic screens in zebrafish have identified a mutation called narrowminded, 
which supports a shared lineage between CNS and PNS cells. This mutant lacks both 
early neural crest cells (PNS) and sensory neurons in the neural tube (CNS) (Artinger et 
al., 1999). Further evidence for a common neural progenitor comes from isolation of stem 
cells from the spinal cord neuroepithelium (NEP) cells that can form both CNS and PNS 
derivatives (Kalyani et al., 1998).  
Not only has it been shown the neural tube/neural crest lineage is shared, but it 
has also been demonstrated that these cells are not irreversibly committed to either fate 
until relatively late in development. The ability of the neural tube to produce neural crest 
cells may persist for long periods. Sharma et al. (Sharma et al., 1995a) identified a late-
emigrating population of neural tube cells that form neural crest-like derivatives. When 
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transplanted into neural crest migratory pathways of younger embryos, these cells can 
migrate and differentiate into neural crest derivatives (Korade and Frank, 1996). 
Conversely, it has been shown that early-migrating neural crest cells can reincorporate 
into the ventral neural tube and express markers characteristic of floor plate cells when 
challenged by transplantation (Ruffins et al., 1998). In addition to neural crest cells which 
arise from the dorsal portion of the neural tube, there is evidence that mulitpotent 
precursors can arise from the ventral neural tube.  These “VENT” cells appear to have the 
ability to form neural crest-like derivatives as well as other cell types (Sohal et al., 1996).  
 
1.2.2 Neural Crest Induction 
Cell–Cell Interaction at the Neural Plate Border 
 Several theories of neural crest induction exist (reviewed in Baker and Bronner-
Fraser, 1997). Both the mesoderm and the epidermal ectoderm have been shown to have 
the ability to induce neural crest. (This section discusses the evidence for ectodermal 
interactions; see below for a discussion of mesoderm.) The best supported model for 
neural crest induction is one in which cell-cell interaction at the border between neural 
and nonneural ectoderm is responsible for inducing the neural crest. In vivo grafting 
experiments suggest that interactions between presumptive epidermis and neural plate 
can form neural crest cells. In amphibians, epidermis grafted into the neural plate 
generates neural crest cells (Moury and Jacobson, 1990; Rollhäuser-ter Horst, 1980). In 
avians and frogs, neural plate tissue grafted into the epidermal ectoderm results in the 
production of migratory cells expressing neural crest cell markers (Dickinson et al., 1995; 
Mancilla and Mayor, 1996). In vitro co-culture experiments have similarly provided 
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evidence for the sufficiency of the neural plate/epidermal ectoderm interaction to 
generate neural crest cells (Dickinson et al., 1995; Mancilla and Mayor, 1996). 
Interestingly, both the epidermis and the neural plate cells contributed to the neural crest 
cell population (Dickinson et al., 1995; Moury and Jacobson, 1990). 
 The potential for more ventral neural tube cells to generate neural crest was 
examined in ablation experiments in which the dorsal region of the neural folds 
containing the presumptive neural crest cells was removed, thus bringing more ventral 
regions of the tube into contact with epidermal ectoderm. In this situation, neural crest 
cells were regenerated at the zone of contact (Couly et al., 1996; Hunt et al., 1995; 
Scherson et al., 1993; Sechrist et al., 1995; Suzuki et al., 1997), for a limited period. 
These data show that a very important mechanism of neural crest induction is mediated 
through cell-cell interactions at the border between the epidermal ectoderm and the neural 
plate.  
 
The Role of BMPs in Neural Crest Induction: Setting up the Neural Plate Border Region 
 There is growing evidence, particularly from the Xenopus system, that members 
of the tumor growth factor-ß (TGF-ß) superfamily of signaling molecules play an integral 
role in setting up the border between neural and nonneural ectoderm. Given that neural 
crest cells arise at this border, it is likely that these cells are an important target of this 
signaling process.  
 Several lines of evidence support the idea that bone morphogenic protein (BMP) 
molecules play a role in neural induction (for review, see refs. 15 and 16). Xenopus BMP-
4 is expressed throughout the ectoderm prior to neural induction and then is lost from 
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regions fated to become the neural plate (Cox and Hemmati-Brivanlou, 1995; Dale et al., 
1992; Fainsod et al., 1994). The secreted BMP antagonists noggin (Lamb and Harland, 
1995; Lamb et al., 1993), chordin (Piccolo et al., 1996; Sasai et al., 1994), and follistatin 
(Fainsod et al., 1997; Hemmati-Brivanlou et al., 1994) all are expressed in Spemann’s 
organizer, the tissue responsible for patterning the ectoderm. Thus, the neural plate forms 
adjacent to the organizer, the source of BMP inhibition, whereas the nonneural ectoderm 
lies distal to the organizer (Fig. 3).  
 One possibility is that inhibition of BMP signaling is sufficient to generate both 
the neural plate and the neural crest, with high levels of inhibition yielding neural tissue 
and intermediate levels yielding neural crest. The idea that a diffusible morphogen could 
act to instruct the ectoderm to assume the various available fates was first proposed by 
Raven and Kloos (Raven and Kloos, 1945), who hypothesized that an “evocator” present 
in a graded fashion could generate neural crest at low levels and neural plate and neural 
crest at high levels (reviewed in ref. 19). In Xenopus ectodermal explants (animal caps), 
varying the level of BMP activity leads to varying fates of ectoderm (Knecht et al., 1995; 
Wilson and Hemmati-Brivanlou, 1997). Overexpression of a dominant-negative BMP 
receptor (Marchant et al., 1998) or the BMP antagonist chordin in Xenopus ectodermal 
explants causes neural crest marker expression and in whole embryos enhances the neural 
crest domain in a dose-dependent fashion (LaBonne and Bronner-Fraser, 1998). In 
contrast, the reciprocal experiment of overexpressing BMP-4 itself in intact embryos does 
not influence the size of the neural crest domain. Instead, the size of the neural plate 
decreases in a dose-dependent fashion, thus moving the location, but not the extent, of the 
presumptive neural crest (LaBonne and Bronner-Fraser, 1998). Furthermore, chordin by 
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itself cannot induce robust expression of neural crest markers in Xenopus animal caps 
(LaBonne and Bronner-Fraser, 1998). Taken together, these results indicate that 
inhibition of BMP signaling alone is not sufficient to induce neural crest formation.  
 
Genetic Evidence for the Involvement of TGF-ß Family Members in Neural Crest 
Induction 
 Genetic evidence in the zebrafish supports a role for TGF-ß family molecules 
influencing the fate of the ectoderm. Nguyen et al. (Nguyen et al., 1998) have 
investigated swirl (Hammerschmidt et al., 1996; Kishimoto et al., 1997), a mutation in 
the zebrafish BMP-2 gene. Swirl mutants display a loss of neural crest progenitors, 
whereas mutations in genes downstream of BMP-2b such as somitabun (mutation in 
Smad5, a BMP signal transducer) expand the neural crest domain (Nguyen et al., 1998). 
The zebrafish mutant radar, which affects a dpp-Vg1-related molecule distinct from the 
BMP-2/4 and BMP-5/8 subgroups ((Delot et al., 1999); and see ref. (Hogan, 1996) for a 
review of TGF-ß relationships), results in the loss of the neural crest marker msxC and -
selected neural crest derivatives. Conversely, overexpression of the radar gene causes 
upregulation of msxC expression, but only in areas contiguous with the endogenous 
msxC domain (Delot et al., 1999). In these mutants, however, the mesoderm underlying 
the neural crest is also affected, allowing for the possibility that the strength of the 
phenotype is not solely due to changes in BMP signaling in the ectoderm. This suggests 
that the activity of TGF-ß family members contributes to the patterning of the ectoderm. 
However, only certain regions are competent to respond to these molecules, suggesting 
that other gene activities may be required for the establishment of the neural crest. 
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Transgenic mice bearing null mutations in BMP-4 (Winnier et al., 1995), 
follistatin (Matzuk et al., 1995), or noggin (McMahon et al., 1998) do not display the 
neural defects that would be expected by extrapolation from the experiments in Xenopus 
described above. It has been suggested that redundancy between different BMP family 
members, the antagonizing molecules, or other developmental defects may obscure the 
phenotype (reviewed in ref. (Bjornson et al., 1999)). Alternatively, there may be 
interesting species differences in the process of neural induction and neural crest 
formation. Indeed, many studies in the chick embryo have added to the interspecies 
discrepancies that are found upon investigation of the role of TGF-ß signaling as a 
mechanism for neural induction and neural crest formation.  
 
BMPs Can Induce Neural Crest in Culture  
 In the chick embryo, BMP-4 and BMP-7 are expressed in the epidermal ectoderm 
that contacts the neural tube (Liem et al., 1995; Schultheiss et al., 1997). As development 
proceeds, however, expression is lost in the epidermal ectoderm but BMP-4 is expressed 
in the neural folds and dorsal neural tube (Watanabe et al., 1996), along with another 
TGF-ß family member, dorsalin-1, which is upregulated after neural tube closure (Liem 
et al., 1995; Streit et al., 1998). When added to isolated intermediate neural plates in 
tissue culture, both BMP-4 and -7 have been shown to induce neural crest markers and 
migratory cells (Liem et al., 1995). This seemingly contrasts with the results in Xenopus, 
where inhibition of BMP signaling yields neural fates. However, the paradigm for neural 
induction by BMP repression in the neural plate does not appear to function in the chick 
embryo at the time of neural crest/neural plate border formation. Chordin, which inhibits 
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BMP activity, is expressed in the avian organizer (Hensen’s node) but alone cannot 
neuralize ectoderm (Streit et al., 1998). Additionally, neither BMP-4 nor -7 is sufficient 
to repress neural induction in the neural plate when ectopically expressed (Streit et al., 
1998).  
 Furthermore, by implanting noggin-producing cells into the neural tube or under 
the neural fold regions, it has been shown that BMP signaling is required in the chick 
neural tube for expression of neural crest markers, but not at the stage at which BMP is 
expressed in the ectoderm (Selleck et al., 1998). Pera et al. (Pera et al., 1998) found that 
ectopic expression of BMP-2 or -4 under the neural/nonneural border region distorts the 
neural plate and causes epidermal ectoderm marker expression in areas that would 
normally give rise to neural plate. Taken together, these results seem to indicate that 
BMP signaling plays several important roles in neural crest development, beginning with 
the positioning of the neural plate border and continuing with the maintenance of neural 
crest induction. Importantly, it is likely that other molecules are involved in the initiation 
of neural crest induction. Later, BMPs in the dorsal neural tube induce roof plate cells 
and sensory neurons (Liem et al., 1997). Still later, BMPs are involved in the 
differentiation of sympathoadrenal precursors from neural crest cells (Anderson, 1993; 
Schneider et al., 1999; Varley et al., 1998).  
 There is no direct evidence that either BMP-4 or -7 is the molecule that diffuses 
from the epidermal ectoderm to induce crest cells (Liem et al., 1995). Indeed, it was 
shown that BMP-4 induces epidermis at the expense of neural tissue (Wilson and 
Hemmati-Brivanlou, 1995). The ability of BMP-4 and -7 to induce neural crest from 
neural plate cultures (Liem et al., 1995; Liem et al., 1997) may be a reflection of the 
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molecule having first induced epidermis, which in turn interacted with the neural plate to 
induce neural crest. Another possibility is that exogenous BMP bypasses an epidermal 
signaling event and mimics a later action of endogenous BMP signaling in the dorsal 
neural tube that is sufficient to generate neural crest cells. This possibility is supported by 
the later neural tube requirement for BMP signaling to produce neural crest cells, as 
demonstrated by Selleck et al. (Selleck et al., 1998). Thus, the action of BMPs may be 
required within the responding tissues to maintain crest production, rather than being a 
property of the initial induction (reviewed in ref. 21). 
 It is important to bear in mind that although many experimental differences 
between species are reported in the literature, these are most likely to be a result of the 
rather striking differences among the organisms that are used for study. Differences in 
morphology and timing of development must require differences in gene expression to 
achieve the overall goal of properly forming the animal. For example, the frog embryo 
begins as a hollow ball of cells, whereas the chick embryo begins as a flat sheet of cells. 
In the frog embryo, development relies for a period on maternal stores of messenger 
RNAs, which contrasts with the chick embryo. Moreover, the distances between 
signaling centers and their responding tissues may require different mechanisms in order 
to effect induction of neural tissue and other developmental events. Although there are 
many apparent species differences, these may reflect variations in the finer details that 
accommodate spatial and temporal variations among organisms; the general mechanisms 
are likely to be common for all vertebrates (LaBonne and Bronner-Fraser, 1999).  
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Other Sources of Neural Crest-Inducing Signals: 
The Mesoderm 
It would be overly simplistic to assume that a single signaling event within the 
ectoderm is sufficient to account for induction of the neural crest. Many lines of evidence 
suggest that the nonaxial mesoderm is also involved in inducing the neural crest. 
Although conjugating epidermis and neural plate in vitro is sufficient to induce neural 
crest markers in the absence of mesoderm (Dickinson et al., 1995; Mancilla and Mayor, 
1996; Moury and Jacobson, 1990), mesoderm could represent an important modifier. 
Mesoderm/neural plate conjugates do not induce early neural crest markers (Dickinson et 
al., 1995; Mitani and Okamoto, 1991). However, it was demonstrated that paraxial 
mesoderm conjugated with neural plate could induce the formation of melanocytes, a 
neural crest derivative (Dickinson et al., 1995). Similarly, non-axial mesoderm from both 
chick and frog can induce neural crest markers in neural plate co-culture experiments 
(Bang et al., 1997; Bonstein et al., 1998; Marchant et al., 1998), and removal of the 
nonaxial mesoderm before neural induction is complete results in a failure of the 
ectoderm to express neural crest markers (Bonstein et al., 1998; Marchant et al., 1998). 
The evidence that mesoderm can influence neural crest formation suggests that there may 
be other molecules involved in the early steps of neural crest induction.  
 
Wnt Family Members  
 As discussed above, it seems likely that inhibition of BMP alone cannot account 
for neural crest induction, making it probable that other signaling systems are involved. 
Possible candidates for involvement in this process are secreted molecules expressed in 
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both mesoderm and ectoderm, that have been implicated in patterning the neural tube. 
These include members of the wingless/int family known in vertebrates as Wnts (Wodarz 
and Nusse, 1998) and the fibroblast growth factor (FGF) family (Sieber-Blum, 1998; 
Vaccarino et al., 1999). In Xenopus ectodermal explants (animal caps), Wnt1 and Wnt3a 
(Saint-Jeannet et al., 1997), Wnt7b (Chang and Hemmati-Brivanlou, 1998), and Wnt8 
(LaBonne and Bronner-Fraser, 1998), in conjunction with inhibition of BMP signaling 
(i.e., neural induction) can induce the expression of neural crest markers. Furthermore, 
overexpression of ß-catenin (a downstream component of the Wnt signaling pathway) 
expands the neural crest domain; expression of a dominant-negative Wnt ligand 
eliminates the neural crest domain in Xenopus embryos (LaBonne and Bronner-Fraser, 
1998). 
 One of the earliest neural crest markers in Xenopus is the zinc finger transcription 
factor, Slug (Mayor et al., 1995) (Fig. 4). When animal caps overexpressing Slug are 
juxtaposed to Wnt8-expressing explants, neural crest markers are induced, thus bypassing 
the requirement for inhibition of BMP signaling (LaBonne and Bronner-Fraser, 1998). In 
contrast, Slug alone cannot induce neural crest (LaBonne and Bronner-Fraser, 1998). 
Slug, in turn, can expand its own expression domain when overexpressed in the whole 
embryo (LaBonne and Bronner-Fraser, 1998). These results suggest that a two-signal 
model may account for the events underlying neural crest formation, such that Wnt 
signaling together with inhibition of BMP signaling induces the neural crest marker, 
Slug, with Slug expression abrogating further need for BMP inhibition (LaBonne and 
Bronner-Fraser, 1998). A recent study has shown that in Xenopus, Wnt signals induce the 
expression of the proto-oncogene c-Myc in neural crest cells prior to the expression of 
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Slug (Bellmeyer et al., 2003). Knock-downs of c-Myc activity result in a loss of neural 
crest cells and their derivatives in vivo (Bellmeyer et al., 2003).  
 Many Wnt molecules are expressed in spatiotemporal patterns appropriate for 
involvement in various aspects of neural crest development. Xenopus Wnt8 is expressed 
in the ventrolateral mesoderm (Christian et al., 1991), a tissue that has been shown to be a 
neural crest inducer when conjugated with neural plate in vitro (Bang et al., 1997; 
Bonstein et al., 1998; Marchant et al., 1998), and avian Wnt-8C is similarly expressed in 
the nonaxial mesoderm (Hume and Dodd, 1993). In Xenopus, an early Wnt8 signal 
induces expression of Pax3 and Msx-1 in the lateral neural plate (Bang et al., 1999). This 
establishes a posteriolateral domain from which neural crest cells will eventually arise 
(Bang et al., 1999). Xenopus Wnt7b is expressed throughout the ectoderm at gastrulation 
(Chang and Hemmati-Brivanlou, 1998), and other Wnts may well be expressed in the 
ectoderm.  
 In chick (Dickinson et al., 1995; Hollyday et al., 1995), frog (McGrew et al., 
1997; Wolda et al., 1993), and mouse embryos (Parr et al., 1993; Roelink and Nusse, 
1991), Wnt1 and Wnt3a are expressed in the dorsal neural tube well after the initial -
expression of neural crest markers, although Xenopus Wnt3a is also expressed before 
neural tube closure at the edges of the neural plate (McGrew et al., 1997). Furthermore, 
avian neural crest can be induced in conjugates of epidermis and neural plate without the 
concomitant expression of either Wnt1 or Wnt3a (Dickinson et al., 1995). This suggests 
that Wnt-1 and -3a are not involved in the initial induction of neural crest. However, 
Wnt1/3a double knockout mice have a reduction in neurogenic and gliogenic neural crest 
derivatives, suggesting that fewer neural crest cells emerge in embryos lacking both 
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genes (Ikeya et al., 1997). Not all neural crest derivatives are affected, with ventralmost 
derivatives such as sympathetic ganglia demonstrating normal morphology, whereas 
dorsal root ganglia are markedly reduced. This is consistent with the possibility that these 
Wnts play a later maintenance role in neural crest production by the neural tube. Wnts 
may be involved in the expansion of neural crest progenitors, most likely by regulating 
the proliferation of the cells after induction has occurred but prior to commencement of 
emigration (Ikeya et al., 1997). Garcia-Castro et. al. (Garcia-Castro et al., 2002) have 
recently shown that a Wnt family member, Wnt6, is likely the early epidermal neural 
crest inducer in the chick. Wnt6 is expressed in the ectoderm adjacent to the neural folds, 
but not in the neural folds and neural plate, at a time when neural crest cells are being 
induced. Drosophila Wingless protein, which activates Wnt singalling in vertebrates, can 
induce neural crest from naïve neural plate in vitro in the absence of additives, whereas 
Wnt inhibition blocks neural crest formation in vivo. Taken together, these results 
demonstrateing that Wnt signaling is both necessary and sufficient to induce neural crest 
in avian embryos (Garcia-Castro et al., 2002).  
 Wnt family members may also be able to control some aspects of neural crest cell 
fate. In zebrafish experiments, single neural crest cells overexpressing molecules of the 
Wnt signaling pathway form pigment cells at the expense of neurons or glia. Conversely, 
overexpressing inhibitors of the pathway biases the neural crest cells to form neurons at 
the expense of pigment cells (Dorsky et al., 1998).  
Recent work by Baker et al. (Baker et al., 1999) has put forward a novel model 
for Wnt function. They demonstrate that expression of Xenopus Wnt8, mouse Wnt8, and 
downstream Wnt targets in frog ectodermal explants can induce expression of the early 
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panneural marker neural cell adhesion molecule (NCAM), without neural induction by 
BMP antagonists. Additionally, they demonstrate that Wnt signaling components 
suppress BMP-4 expression in ectoderm explants as assayed by in situ hybridization. In 
fact, Wnt8, and not the BMP antagonist noggin, seems to be capable of blocking BMP-4 
expression in the neural plate throughout gastrula stages, suggesting that an early Wnt 
signal and not a direct BMP antagonist is responsible for the early inhibition of BMP-4 
expression in the neural plate. Finally, the authors suggest that there may be parallel 
pathways for the effects of Wnt signaling in neural induction since inhibition of Wnt8-
mediated activation of the neural inducers Xnr3 and siamois did not abrogate Wnt8’s 
ability to itself promote neural induction. These results suggest that Wnt signaling may be 
involved in multiple inductive events in early development. The ramifications of these 
data for the role of Wnt signaling in neural crest induction are unclear, as these 
investigators did not explore the effects of the perturbations on neural crest markers. 
Previous results showing that Wnts could not induce neural crest without a co-expressed 
neural inducer (Chang and Hemmati-Brivanlou, 1998; LaBonne and Bronner-Fraser, 
1998; Saint-Jeannet et al., 1997) taken together with the results of Baker et al. (Baker et 
al., 1999) may indicate that the precise levels of Wnt signaling are critical. Further 
investigation will be required to determine exactly what role Wnt plays during neural 
crest development. 
 
Fibroblast Growth Factors 
Other molecules expressed in the mesoderm have been shown to have neural crest 
inducing activities. FGF signaling can induce neural crest markers in frog ectodermal 
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explants when in the presence of BMP antagonists (Kengaku and Okamoto, 1993; 
LaBonne and Bronner-Fraser, 1998; Mayor et al., 1997). Overexpression of a dominant-
negative FGF receptor can inhibit expression of the early neural crest marker XSlug in 
whole embryos (Mayor et al., 1997). Other investigators have demonstrated that FGF 
signaling has a posteriorizing effect on neural tissue (Cox and Hemmati-Brivanlou, 1995; 
Kengaku and Okamoto, 1993; Lamb and Harland, 1995; Launay et al., 1996; Xu et al., 
1997). Indeed, members of the FGF family are spatiotemporally expressed in a way that 
is consistent with their playing roles in the process of neural and/or neural crest induction 
(Bueno et al., 1996; Isaacs et al., 1992; Mahmood et al., 1995; Riese et al., 1995; Storey 
et al., 1998; Streit et al., 2000). Recent work by Streit et al. has shown that in the chick, 
an FGF signal from Hensen’s node initiates neural induction prior to the onset of 
gastrulation, inducing the expression of early neural genes such as ERNI, Sox2, and Sox3 
(Streit et al., 2000). The results indicate that FGFs may be able to generate both posterior 
and lateral (i.e., neural crest) fates in the CNS and PNS. The role of FGFs becomes 
complicated in light of evidence from transgenic frog experiments, however, in which 
frog embryos expressing a dominant-negative FGF receptor have normally developing 
posterior neural tissue and border regions including the neural crest, although the 
investigators did not test a full range of neural crest markers (Kroll and Amaya, 1996). 
Moreover, FGF-treated neural plate explants do not form neural crest tissue (Mayor et al., 
1997). Another recent study suggests that fibroblast growth factor FGF-8 may mediate 
the inductive effects of paraxial mesoderm on frog animal caps and may be sufficient to 
induce expression of several neural crest markers (Monsoro-Burq et al., 2003). However, 
other assays suggest that, neural crest induction by FGF may be a secondary result of its 
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ability to induce a member of the Wnt family (LaBonne and Bronner-Fraser, 1998).  
 
Notch and Noelin 
 Recent work has implicated both Notch signaling and Noelin-1 in the generation 
of neural crest cells. Activation of the Notch receptor results in cleavage of its 
intracellular domain, which translocates to the nucleus and activates transcription 
(Kopan, 2002). Notch1 is expressed throughout the neural plate, with higher levels in the 
neural crest, whereas its ligand Delta1 is expressed in the epidermal ectoderm (Almqvist 
et al., 2002; Bierkamp and Campos-Ortega, 1993; Coffman et al., 1993; Williams et al., 
1995). Notch signaling has been shown to be required for neural crest formation in avian, 
zebrafish, and Xenopus embryos (Almqvist et al., 2002; Cornell and Eisen, 2002) (Glavic 
et al., 2004), perhaps by repressing Neurogenin-1 function (Cornell and Eisen, 2002).. In 
the chick and Xenopus, Notch promotes neural crest formation by modulating levels of 
BMP4 expression: in the chick, Notch maintains BMP4 expression (Almqvist et al., 
2002), whereas in Xenopus Notch represses BMP4 transcription (Glavic et al., 2004). In 
zebrafish, Notch promotes formation of neural crest by repressing Neurogenin-1 
function(Cornell and Eisen, 2002).  
 Barembaum, et al have recently demonstrated that the secreted glycoprotein 
Noelin-1 plays a role in the competence of neural tissue to form neural crest formation 
(Barembaum et al., 2000). Noelin-1 mRNA is restricted to the dorsal neural folds and 
migrating neural crest cells in avian embryos. Retroviral-mediated overexpression of 
Noelin-1 in the neural tube increases both the number of neural crest cells generated and 
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the length of time neural crest cells continue to emigrate from the neural tube. These 
findings suggest that Noelin-1 may play a role in rendering the neural tube cells 
competent to form neural crest (Barembaum et al., 2000).  
 
1.2.3 Neural Crest Stem Cells 
 In the past decade, work by several investigators has led to the prospective 
identification and purification of neural crest stem cells—cells with the potential to self-
renew and also to give rise to the diverse population of derivatives that are generated by 
the neural crest. The first neural crest stem cells were isolated in vitro by clonal analysis 
of cells that were fractionated from rat neural crest cultures by cell sorting based on 
expression of a cell surface epitope (Stemple and Anderson, 1992). These cells can be 
replated to form new stem cells and also can give rise to “blast” cells that are partially 
restricted to form neurons or glia. These include the sympathoadrenal sublineage, which 
includes precursors to sympathetic neurons and adrenomedullary cells (Doupe et al., 
1985), that, in the embryo, appear specified by the time that neural crest-derived cells 
reach their sites of localization around the dorsal aorta.  
 Specific molecules can instruct neural crest stem cells to adopt specific fates; for 
example, glial growth factor (neuregulin) causes the development of glia (Schwann cells) 
BMP-2 biases clones to develop into neurons (and a small number of smooth muscle 
cells), and TGF-ß1 promotes development of smooth muscle cells (Morrison et al., 1997; 
Shah et al., 1996; Shah et al., 1994). It has recently been shown that transient Notch 
activation promotes glial production by neural crest stem cells at the expense of 
neurogenesis, even in the presence of BMP-2 (Morrison et al., 2000). Thus, it is 
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interesting to note that members of the TGF-ß superfamily are not only involved in 
induction of the neural crest but are also implicated in subsequent cell fate decisions.  
 Although the neural crest stem cells are very useful in testing the ability of factors 
to promote certain cell fate decisions, there are possible caveats; for example, the stem 
cell qualities of the purified cells may have been acquired in vitro and may not reflect an 
actual state that is present in the embryo. The findings of Frank and colleagues (Korade 
and Frank, 1996; Sharma et al., 1995a)  that neural tubes can give rise to neural crest-like 
cells that emigrate long after the normal period of neural crest formation suggest that 
neural crest stem cells may persist within the spinal cord and other sites for long periods. 
Consistent with this possibility, Morrison et al. (Morrison et al., 1999) have recently 
isolated neural crest stem cells from embryonic rat peripheral nerve at E14.5. The cells 
were isolated by fluorescence-activated cell sorting using cell surface epitopes p75 and 
P0. Under proper culture conditions, these cells self-renew and can differentiate into 
neurons, glia, and smooth muscle cells within single colonies. The cells are also 
instructively promoted to form neurons or glia by exposure to either BMP-2 or glial 
growth factor, respectively, in clonal cultures. An important test of the qualities of these 
neural crest stem cells is to determine whether newly isolated cells are multipotent when 
transplanted into an embryo. Indeed, freshly isolated cells that were p75 + /P0 - have 
stem cell properties and can be back-transplanted into chick embryos, giving rise to both 
neurons and glia as assayed by differential marker expression (Morrison et al., 1999). 
However, neural crest stem cells sorted from E14.5 rat spinal cords have been shown to 
have cell-intrinsic differences in developmental potential in vivo from their counterparts 
cultured E10.5 neural tube explants (White et al., 2001). The older, sorted neural crest 
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cells produce fewer neurons and appear unable to give rise to noradrenergic neurons, due 
to reduced sensitivity to the neurogenic signal BMP-2 (White et al., 2001). This 
phenomenon suggests that neural crest stem cells can change as a function of time and 
perhaps in response to local environmental factors in the periphery. By labeling actively 
dividing cells in embryos with the thymidine analog bromodeoxyuridine, it was shown 
that endogenous neural crest stem cells persist in the embryo by self-renewing (Morrison 
et al., 1999).  
Self-renewing neural crest stem cells have also recently been isolated by flow 
cytometry from both embryonic (Bixby et al., 2002) and adult (Bixby et al., 2002) gut. 
Gut neural crest stem cells can be sorted based on expression of both p75 and α4 integrin 
(Bixby et al., 2002). The prospective isolation of gut neural crest stem cells has proven 
particularly important toward the understanding of Hirschsprung disease, a common gut 
motility defect caused by the absence of enteric nervous system ganglia in the hindgut 
(Iwashita et al., 2003). Gut neural crest stem cells from normal mice were found to 
express high levels of the glial cell line-derived neurotrophic factor (GDNF) receptor 
receptor Ret, and GDNF promoted migration of neural crest stem cells (Iwashita et al., 
2003). Ret -/-null mice were found to have far fewer neural crest stem cells in the gut as 
compared to wild type mice (Iwashita et al., 2003). Yet there were no differences in 
proliferation, differentiation, or survival between neural crest stem cells from normal and 
mutant mice, suggesting that the absence of enteric ganglia in Ret null  mice is caused by 
a failure of Ret null neural crest stem cells to migrate into the distal gut (Iwashita et al., 
2003).  
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1.3 LINEAGE AND CELL FATE DECISIONS IN THE NEURAL CREST 
 The existence of neural crest stem cells in the embryo supports the idea that the 
fate of neural crest cells in vivo is primarily determined by their environment (Barbu et 
al., 1986). Neural crest cell fate decisions and their relationships to cell lineage have been 
debated for many years. Although it has been accepted that at least some, if not most, 
neural crest cells are multipotent, some evidence indicates that other neural crest cells 
have restricted fates in vivo (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and 
Fraser, 1989; Frank and Sanes, 1991). However, in these experiments, the potential of the 
cells has not actually been tested by challenging the cells with all possible factors that 
might influence cell fate choice. It is obviously difficult to quantify and compare the 
environment of one cell with another, beginning from their origins in the neural tube and 
following their migration trajectories through the periphery. In these lineage experiments, 
single dye-labeled or retrovirally tagged cells often gave rise to clones of progeny with 
multiple derivatives but sometimes gave rise to clones of only one cell type, suggesting 
an earlier specification for that progenitor cell. Thus, alternate methods of marking and 
challenging neural crest cells will be necessary to define the state of multipotency at the 
single cell level. This is an area in which the neural crest stem cells and their blast cells 
promise to provide new and important information. 
Recent work has shown that the HMG-group transcriptional regulator Sox10 
maintains the multipotency of neural crest stem cells (Kim et al., 2003). In rodents, 
Sox10 is expressed in neural crest cells at the time of their emigration from the dorsal 
neural tube.  Loss-of-function mutations in Sox10 result in defects in multiple neural 
crest derivatives (Southard-Smith et al., 1998). Interestingly, over-expression of Sox10 in 
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neural crest stem cells maintains their neurogenic and gliogenic potentials, despite 
challenges by opposing differentiation factors such as BMP2 or TGF-ß (Kim et al., 
2003).  
 
1.3.1 Mechanisms of Neural Crest Diversification 
If neural crest cells are truly multipotent and only receive instructions for 
differentiation when migrating to or reaching their final destinations, then it is interesting 
to consider how cells are instructed to take on different fates. For example, neural crest 
cells in the dorsal root ganglia differentiate into both sensory neurons and glia. An 
asymmetric cell division could produce a blast cell of each type, which could in turn 
replicate. Alternatively, the progenitor may replicate itself and produce a more restricted 
daughter cell, which then goes on to form the final derivatives. The latter seems more 
likely given the ability of neural crest stem cells to self-renew. 
 
1.3.2 Environmental Cues versus Timing of Emigration 
 Both the environment and the timing of emigration from the neural tube have 
been proposed to affect the cell fate decisions of the neural crest. A restriction in 
available cell fate accompanies the time of emigration from the neural tube: the latest 
migrating cells only populate the dorsal root ganglia as neurons and form melanocytes in 
the skin and feathers (Serbedzija et al., 1989; Sharma et al., 1995a). However, when 
transplanted into earlier embryos, neural crest-like cells derived from much older spinal 
cords were able to migrate more ventrally and make sympathetic and peripheral neurons 
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(Korade and Frank, 1996; Weston and Butler, 1966). Similarly, in the head, late-
migrating cells only formed dorsal derivatives because of the presence, ventrally, of 
earlier migrating cells; however, they are not restricted in potential (Baker and Bronner-
Frase, 1997). Furthermore, the latest migrating cells of the main wave of crest emigration 
make melanocytes in the skin, but skin culture experiments show that they have the 
potential to form neurons (Richardson and Sieber-Blum, 1993). This suggests that the 
restriction in available fates in these cases is made by the environment that the cells 
occupy rather than the time that they emerge from the neural tube (Fig. 1).  
 Additional evidence for the influence of environment on neural crest cell fate 
comes from neural crest stem cells, in which single progenitor cells can generate smooth 
muscle cells when exposed to TGF-ß molecules. However, a community effect takes 
place when denser cultures are exposed to TGF-ß molecules, such that either neurons 
form or cell death occurs, rather than differentiation of smooth muscle cells (Hagedorn et 
al., 1999). These data suggest that cell fate in the embryo could also be determined by 
community effects in which cells respond differently to the same factors depending on 
the density of neighboring cells (Hagedorn et al., 1999). Other interesting studies on 
neural crest stem cells reveal that they can integrate multiple instructive cues and are 
biased to certain levels of responsiveness based on the growth factors to which they are 
exposed. If cultures of neural crest stem cells are exposed to saturating levels of both 
BMP-2 and glial growth factor (neuregulin), BMP-2 appears dominant and neurons 
differentiate. However, BMP-2 and TGF-ß1 seem to be co-dominant (Morrison et al., 
1997). 
There is evidence, however, that some neural crest cell populations may undergo 
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early fate restrictions. By culturing “early-migrating” and “late-migrating” trunk neural 
crest cells, Artinger and Bronner-Fraser (Artinger and Bronner-Fraser, 1992) found that 
the latter are more restricted in their developmental potential than the former; although 
they can form pigment cells and sensory-like neurons, they fail to form sympathetic 
neurons. Additionally, late-migrating cells transplanted into an earlier environment can 
colonize the sympathetic ganglia but failed to form adrenergic cells (Artinger and 
Bronner-Fraser, 1992). Thus, the time that a precursor leaves the neural tube may 
contribute to its potency. Perez et al. (Perez et al., 1999) have provided evidence for early 
specification of sensory neurons by the basic helix-loop-helix transcription factors 
neurogenins 1 and 2. These molecules are expressed early in a subset of neural crest cells, 
and ectopic expression of the molecules biases migrating neural crest cells to localize in 
the sensory ganglia and express sensory neuron markers.  
The mechanism for formation of sensory neurons from neural crest cells has 
remained a mystery until recently. In an elegant set of experiments, Lee et al have 
demonstrated that activation of the canonical Wnt signaling pathway instructs neural 
crest cells to adopt a sensory neuronal fate (Lee et al., 2004). Transgenic mice in which a 
constitutively active form of ß-catenin, a key mediator in the canonical Wnt signaling 
pathway, was selectively expressed in neural crest cells produced only sensory neurons at 
the expense of other neural crest derivatives (Lee et al., 2004). Moreover, exogenous Wnt 
added to clonal cultures of neural crest cells in vitro similarly biased the cells toward a 
sensory neuronal phenotype without altering their proliferation (Lee et al., 2004).  
 Recent work implicates FGF and Wnt signaling in influencing the fate decisions 
of neural crest cells(Lee et al., 2004; Trainor et al., 2002). Hoxa2 expression in hindbrain 
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neural crest appears to confer second brancial arch identity at, causing them to form 
second arch skeletal elements in the head (Grammatopoulos et al., 2000; Pasqualetti et 
al., 2000). Trainor et al have shown that FGF8 signals alone or from the isthmic organizer 
can inhibit Hoxa2, allowing second-arch cells to adopt a first-arch fate and duplicate first-
arch skeletal structures (Trainor et al., 2002).  
 The study of neural crest stem cells has yielded new insight into the effects of 
environment and timing on the function of neural crest cells (Bixby et al., 2002; Morrison 
et al., 1999). Bixby et al have compared the properties of neural crest stem cells purified 
from the sciatic nerve and gut of rat embryos at E14, a time at when neurogenesis is 
predominant in the gut while gliogenesis is most prevalent in nerves (Bixby et al., 2002). 
In both cell culture and transplantation experiments, gut neural crest stem cells produced 
primarily neurons, a function of their increased sensitivity to BMP4, whereas sciatic 
nerve neural crest stem cells formed mostly glia, due to their enhanced sensitivity to 
neuregulin and the Notch ligand Delta (Bixby et al., 2002). These stem cells maintain 
their difference even after many days of culture and subcloning, suggesting that the 
differences are intrinsic to the cells (Bixby et al., 2002). In contrast, neural crest stem 
cells purified from postnatal rat gut formed primarily glia after they were transplanted 
into the peripheral nerves of chick embryos, demonstrating that gut neural crest stem cells 
undergo temporal changes that help determine their cell fates in vivo (Bixby et al., 2002). 
Some important questions arise from this work: What signals cause the spatial and 
temporal differences observed in different neural crest stem cells? What are the normal 
functions of neural crest stem cells that persist into adulthood?  
Another way to account for the process of promoting two different cell fates from 
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one precursor population within a single tissue is the proposal that temporal changes in 
the target environment bias the cell fate decision (Frank and Sanes, 1991). This is 
supported by the fact that first neurons and then glia are born in the dorsal root ganglia 
(e.g., ref. (Carr and Simpson, 1978)). The target environment could be influenced to 
change by early differentiating neural crest cells themselves; for example, some neurons 
produce glial-promoting factors (Lemke, 1996; Marchionni et al., 1993; Meyer and 
Birchmeier, 1995; Meyer et al., 1997; Morrison et al., 2000; Orr-Urtreger et al., 1993). 
The strongest evidence of this phenomenon comes from the effects of Notch activation 
on cell fate of neural crest stem cells (Morrison et al., 2000). Notch activation by ligands 
such as Delta, which are expressed on differentiating neuroblasts, induces glial 
differentiation at the expense of neurogenesis, even in the presence of BMP2 (Morrison 
et al., 2000). These findings suggest that differentiating neuroblasts might activate Notch 
in neighboring neural crest cells as a feedback signal to promote gliogenesis. Also, the 
loss of certain inhibitory glycoconjugates from the extracellular matrix in the dorsolateral 
migration pathway has been linked to the migration of late-emigrating neural crest cells 
along this pathway (Oakley et al., 1994), where they are exposed to melanogenic factors 
and hence adopt a melanocyte fate (Perris, 1997). Thus, there is evidence for the 
influence of both the timing of emigration and environmental cues in determining neural 
crest fates. 
 
1.3.3 Progressive Lineage Restriction 
It has been proposed that neural crest cells adopt specific fates by progressive 
lineage restrictions (Anderson, 1993; Anderson, 1999; Stemple and Anderson, 1993). 
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One way to explain the intermingling of clonally related neurons and glia is that the 
choice is made stochastically, such that each cell has the capacity to adopt either fate, and 
environmental factors act by influencing the probability of a fate choice rather than 
imposing strict commitments (Frank and Sanes, 1991). Trentin et al have recently taken 
individual avian neural crest cells through multiple rounds of serial recloning to 
demonstrate that both cranial and trunk neural crest cells give rise to progeny cells in a 
hierarchical manner, with progressively restricted developmental potentials, akin to the 
lineage hierarchy formed by hematopoietic stem cells (Trentin et al., 2004). Strikingly, 
they found that only two types of intermediate bipotent precursors, glial-melanocytic and 
glial-myofibroblast precursors had the ability to self-renew (Trentin et al., 2004). Support 
for the idea of progressive fate restriction comes also from the NEP, which can give rise 
to both CNS- and PNS-type stem cells. PNS stem cells (indistinguishable from neural 
crest stem cells, as described in ref. 11) are formed on addition of BMP-2/-4 to the NEP 
cell cultures (Kalyani et al., 1998). BMP-2, a molecule that is known to instruct neural 
crest stem cells toward an adrenergic neuronal fate, is expressed in the dorsal aorta, near 
where sympathetic ganglia form (Bitgood and McMahon, 1995; Lyons et al., 1995; 
Morrison et al., 1997). Thus, there is evidence that environmental cues may be able to 
promote progressive restriction of neural crest cell fates. Many factors act selectively by 
affecting the proliferation or survival of neural crest derivatives; others act instructively 
on multipotent progenitors to promote one fate over another. Further work will be 
required to answer the complex question of how individual cells within the same 
environment can adopt different fates. The evidence in support of both multipotentiality 
and lineage restriction may imply that neural crest cells take cues from both the timing of 
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emigration from the neural tube and the environments to which they are exposed in cell 
lineage decisions. For more discussion on the topic of neural crest diversification, the 
reader is referred to several recent reviews (Anderson, 1993; Groves and Bronner-Fraser, 
1999; LaBonne and Bronner-Fraser, 1998). 
 
 
1.4 CANCER STEM CELLS IN THE CENTRAL AND PERIPHERAL NERVOUS 
SYSTEM 
 
 A great deal of recent interest has focused on the striking similarities between 
stem cells and cancer cells in the nervous and hematopoietic systems as well as in various 
epithelial cell types (Iwashita et al., 2003; Reya et al., 2001). In particular, stem cells and 
some cancer cells share the fundamental properties of self-renewal and the ability to 
differentiate into multiple distinct cell types (Bonnet and Dick, 1997; Sell and Pierce, 
1994; Wechsler-Reya and Scott, 2001).. The mechanisms underlying self-renewal of 
normal stem cells are known to be tightly regulated (Lessard and Sauvageau, 2003; 
Molofsky et al., 2003; Reya et al., 2003). In contrast, self-renewal of cancer cells is, by 
definition, aberrant.  
 The multipotency and self-renewal of some cancer cells raises the possibility that 
cancer might arise from the transformation of normal somatic stem or progenitor cells. In 
many cancers, it is known that only a small subset of cancer cells (called tumor or cancer 
stem cells) is able to drive the growth of the tumor and give rise to secondary tumors in 
vivo.  However, the origins and phenotypes of those cells were unknown (Hamburger and 
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Salmon, 1977). One interesting possibility is that these cancer stem cells may be lineally 
related to transformed stem or progenitor cells.  
 Recent work has identified and characterized cancer stem or stem-like cells in 
leukemia, breast cancer, and brain tumors, and shown that these cells can self-renew, are 
multipotent, and can recapitulate characteristics of the original tumor in vitro and/or in 
vivo (Al-Hajj et al., 2003; Bonnet and Dick, 1997; Hemmati et al., 2003; Ignatova et al., 
2002; Kondo et al., 2004; Singh et al., 2003). The existence of cancer stem cells was first 
proven in acute myeloid leukemia (Bonnet and Dick, 1997). Bonnet and Dick showed 
that a rare subset of cells from this cancer was able to proliferate extensively; in contrast, 
to the majority of leukemic cells have limited proliferative ability (Bonnet and Dick, 
1997). Moreover, these leukemia stem cells, but not non-stem cells from the same 
patients’ population of leukemic cells, could transfer the disease after transplantation into 
immunodeficient mice (Bonnet and Dick, 1997). This hyperproliferative subset of cells 
from these tumors was found to be phenotypically similar to normal hematopoietic stem 
cells based on expression of cell-surface antigens, suggesting that they might be related to 
the normal stem cells (Bonnet and Dick, 1997). However, the possibility exists the 
leukemic stem cells arise from the transformed committed progenitor cells that have 
reacquired stem cell characteristics (Cozzio et al., 2003). To address this question, Cozzio 
et al. recently transduced both hematopoietic stem cells and myeloid progenitor cells with 
a leukemogenic fusion protein, and found that transformation of both cell types produces 
an identical type of tumor in vivo (Cozzio et al., 2003). Therefore, it is possible that 
cancer stem cells arise from cells other than multipotent stem cells (Cozzio et al., 2003).  
 Similar experiments in breast cancer have demonstrated the existence of breast 
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cancer stem cells (Al-Hajj et al., 2003). Al-Hajj et al. used cell surface markers on 
uncultured breast cancer cells to fractionate them into different subsets, and transplanted 
the cells into immunodeficient mice (Al-Hajj et al., 2003). Only cells that phenotypically 
resembled normally mammary epithelial progenitor cells were able to give rise to tumors 
in the mice (Al-Hajj et al., 2003). Moreover, the tumors that formed in mice 
histologically resembled the tumors from which their stem cells were derived and 
themselves contained progenitor cells that formed tumors in other mice, suggesting that 
breast cancer stem cells can self-renew in vivo (Al-Hajj et al., 2003).  
 The search for cancer stem-like cells in central nervous system malignancies has 
recently borne fruit (Hemmati et al., 2003; Ignatova et al., 2002; Kondo et al., 2004; 
Singh et al., 2003). It has been proposed for some time that brain tumors arise from the 
transformation of self-renewing neural stem or progenitor cells (Brustle and McKay, 
1995; Holland, 2000). Aside from the fact that some brain tumors contain both neurons 
and glia, many brain tumors (particularly those occurring in children) arise from the 
ventricular zone, where neural stem cells reside postnatally (Choe et al., 2003; Koos and 
Horaczek, 1985; Sutton et al., 1992) (Sanai et al., 2004). Like neural stem cells, some 
brain tumors  express the intermediate filament nestin, as well as other genes that regulate 
the proliferation of normal neural progenitor cells, such as EGF-R (Almqvist et al., 2002; 
Gilbertson et al., 2001; Rorke et al., 1997; Taipale and Beachy, 2001; Tohyama et al., 
1992; Wechsler-Reya and Scott, 2001). Moreover, expression of oncogenes in neural 
stem or progenitor cells in mice results in the formation of tumors that resemble primary 
human brain tumors (Holland, 2000).  
 Ignatova et al. first showed that primary human cortical anaplastic astrocytoma 
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and glioblastoma multiforme contain cells that, in clonal cultures, produce cells 
expressing neuronal and/or glial markers (Ignatova et al., 2002). Two groups recently 
demonstrated that some cells from pediatric brain tumors (primarily medulloblastomas 
and astrocytomas), like normal neural stem cells, could be directly cultured in serum-free 
medium as floating aggregates known as neurospheres, which were multipotent and could 
self-renew for long periods of time to give rise to secondary neurospheres (Fig. 5) 
(Hemmati et al., 2003; Singh et al., 2003). The neurosphere-forming subset was shown to 
reside in the fraction of cells expressing the cell-surface antigen CD133, a marker of 
human neural stem cells (Singh et al., 2003; Uchida et al., 2000). Hemmati et al. showed 
that tumor-derived progenitors from each patient had a stereotypic pattern of 
differentiation in vitro, yet those patterns were highly variable from one patient to another 
(Hemmati et al., 2003). Strikingly, however, the proportions of neurons, glia, and nestin-
expressing cells produced from differentiated brain tumor-derived progenitor cells in 
vitro strongly correlated with their proportions in the primary tumor of origin (Hemmati 
et al., 2003). Unlike neural stem cells, the tumor-derived progenitors proliferated 
aberrantly and differentiated into unusual cells that co-expressed both neuronal and glial 
markers (Fig. 5G) (Hemmati et al., 2003). These results are consistent with the possibility 
that brain tumor-derived progenitors might be cancer stem cells (Hemmati et al., 2003). 
Short-term studies have demonstrated that brain tumor-derived progenitors can migrate, 
proliferate, and differentiate after transplantation into rat brains, but tests of their ability 
to form tumors in immunodeficient mice are ongoing (Hemmati et al., 2003).  
 In light of these data, might neural crest stem cells or their committed progenitor 
cells be the origins of peripheral nervous system tumors? This seems like a tractable 
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possibility since neural crest stem cells persist into adulthood and are therefore 
susceptible to acquiring transforming throughout life (Bixby et al., 2002).  It has been 
posited that neuroblastomas, the most common solid extracranial tumor in children, arise 
from the transformation of neural crest stem cells or neural crest-derived sympathetic 
precursor cells (Brodeur, 2003; Nakagawara and Ohira, 2004). The recent finding by 
Trentin et. al. that multipotent neural crest cells form a hierarchy that contains lineage-
restricted precursor cells that retain self-renewal ability suggests that those progenitor 
cells might be targets for transformation in the development of certain neural crest-
derived malignancies (Trentin et al., 2004). Specifically, transformation of glial-
melanocyte progenitor cells, which are able to self-renew in vivo, might lead to human 
tumors characterized by the overproduction of glia and melanocytes, such as 
neurofibromas and melanotic Schwannomas (Ferner and O'Doherty, 2002; Riccardi, 
1991). Likewise, glial-myofibroblast progenitor cells might give rise to tumors that 
involve both neural and mesectodermal cells, like Ewing’s sarcomas (Cavazzana et al., 
1987; Thiele, 1991). To address these possibilities, it will be necessary to prospectively 
isolate cancer stem cells from the aforementioned tumors using similar methods to those 
used for CNS tumors. 
What molecular mechanisms might drive normal stem or progenitor cells to 
become malignant? One possibility is that failure of stem cells to regulate their 
endogenous self-renewal pathways causes their neoplastic transformation. One candidate 
molecule that has received much attention in this regard is bmi-1, a polycomb family 
transcriptional repressor that promotes proliferation partly by repressing the expression of 
two cyclin-dependent kinase inhibitors p16-ink4a and p19-Arf (Jacobs et al., 1999). Bmi-
 35
1 was recently shown to be required for the self-renewal of both normal and leukemic 
hematopoietic stem cells (Lessard and Sauvageau, 2003; Molofsky et al., 2003). In the 
nervous system, bmi-1 is required for the self-renewal of both neurosphere-forming 
central nervous system stem cells and neural crest stem cells (Molofsky et al., 2003). 
Expression of bmi-1 has recently been shown to be elevated in cerebellar precursor cells, 
whole human medulloblastomas, and in tumor-derived progenitor cells from 
medulloblastomas and other pediatric brain tumors, even after differentiation (Hemmati 
et al., 2003; Leung et al., 2004). Therefore it is possible that bmi-1 and other regulators of 
proliferation play a role in the pathogenesis of tumors of the central and peripheral 
nervous system.  
 
1.5 CONCLUSIONS 
 
 The demonstration that multiple molecules from different gene families have the 
capacity to induce neural crest implies that the mechanism of neural crest induction 
involves complex and perhaps parallel pathways. It is further interesting to note that the 
same molecules can have multiple inductive capabilities at different times in 
development. Although great strides have been made toward understanding the induction 
and cell fate decisions of the neural crest, many mysteries remain. The field of neural 
crest research is rich in unanswered questions whose solutions will not only offer deeper 
understanding of the mechanisms of neural crest development but will also give more 
general insight into phenomena such as cell migration and differentiation, as well as the 
development of cancers of the peripheral nervous system.  
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Figure 1: Neural crest-forming regions and migration pathways in avians:  cross-sectional view 
(A) E1.5-2.  Thickened epithelium at the midline begins to fold into a tube.  The border of the 
neural and non-neural ectoderm is the site of neural crest formation. 
(B) E2-2.5.  Neural crest cells delaminate from the the dorsal neural tube and begin to migrate. 
(C) E3.  Two migration pathways are shown:  the dorsolateral pathway passes between 
dermomyotome and epidermis, and the ventral pathway passes through the sclerotome of the 
somites. 
(D) E4:  Neural crest cells populate the dorsal root ganglia, sympathetic ganglia, and form 
melanocytes in the skin. 
da, dorsal aorta;  dm, dermomyotome;  drg, dorsal root ganglion;  epi, epidermis;  m, melanocyte;  
meso, non-axial mesoderm;  nc, neural crest;  nt, neural tube;  s, somite;  sg, sympathetic 
ganglion. 
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Figure 2: Diagram illustrating the derivatives arising from trunk and cranial neural crest 
cells. 
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Figure 3: Schematic diagram of the Xenopus model of neural induction 
The BMP antagonists noggin, chordin and follistatin are secreted from 
Spemann's Organizer (black box) to modulate BMP activity in the ectoderm.  The 
activity of BMP molecules establishes three fates of ectoderm:  lowest activity = 
neural plate; intermediate activity = neural crest;  highest activity = epidermis.  
This simplistic model does not include the evidence for the involvement of other 
molecules in neural and neural crest induction, but is intended as a simplified 
model of neural induction. Modified from LaBonne & Bronner-Fraser. 
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Figure 4:  Slug expression pattern in Xenopus and chick 
The zinc-finger transcription factor Slug is an early marker for the neural crest.  
(A):  a late-neurula Xenopus embryo with Slug mRNA expression in the cranial 
neural crest on both sides of the closing neural tube.  The groove down the 
central portion of the embryo is the forming neural tube.  (B):  an E1.5 (10-somite 
stage) chick embryo with Slug mRNA marking the early-migrating neural crest 
in the head (arrowheads) and pre-migratory neural crest at more posterior levels 
of the neural tube. 
a, anterior;  p, posterior;  fb, forebrain;  mb, midbrain;  hb, hindbrain;  nt, neural 
tube. 
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Figure 5: Tumor-derived progenitors form neurospheres in culture that give rise to both 
neuronal and glial cells.  Neurospheres from one tumor, BT1, were cultured at medium (A-D) and 
clonal (E-H) densities. (A) A typical primary neurosphere is round in morphology and contains 
numerous birefringent cells when viewed under phase contrast optics. (B and C) Undifferentiated 
primary neurospheres expressed high levels of nestin protein (B, green) and low levels of (C) βIII-
tubulin (red) and GFAP (green). (D) After 7 days of exposure to differentiation conditions, primary 
neurospheres significantly increased numbers of cells expressing β−III-tubulin and GFAP, and 
produced cells extending processes onto the substrate. (E) Undifferentiated clonal neurosphere cells 
have high levels of nestin expression. (F) Undifferentiated clonal neurospheres expressed the neural 
stem cell marker musashi-1 (green) in nearly every cell.   (G) A neurosphere derived from a single cell 
that, under differentiation conditions, formed cells expressing β−III-tubulin (red) which is 
characteristic of neurons and GFAP (green), which is characteristic of astrocytes. Some cells 
expressed both markers. (H) Differentiated clonal neurospheres produced cells expressing the 
neuronal marker Hu (green) in similar proportions to β−III-tubulin. Some nuclei were counterstained 
with DAPI (F and H, blue). Scale bar in H = 30 µm in A, G, and H, 60 µm in B-F.  Reproduced from 
PNAS with permission.  
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Abstract 
Pediatric brain tumors are significant causes of morbidity and mortality and are of 
unknown cellular origin. An intriguing possibility is that they derive from self-renewing, 
multipotent neural stem cells. Here, we tested whether different pediatric brain tumors, 
including medulloblastomas and gliomas, contain cells with properties similar to neural 
stem cells. We find that tumor-derived progenitors form neurospheres that can be 
passaged at clonal density and are able to self-renew. Under differentiative conditions, 
individual cells are multipotent, giving rise to both neurons and glia, in proportions that 
reflect the tumor of origin. Unlike normal neural stem cells, however, tumor derived 
progenitors have an unusual capacity to proliferate and sometimes differentiate into 
abnormal cells with multiple differentiation markers. Gene expression analysis reveals 
that both whole tumors and tumor-derived neurospheres express many genes 
characteristic of neural and other stem cells, including CD133, Sox2, musashi-1, bmi-1, 
maternal embryonic leucine zipper kinase, and phosphoserine phosphatase, with variation 
from tumor to tumor. After grafting to neonatal rat brains, tumor-derived neurosphere 
cells migrate, produce neurons and glia, and continue to proliferate for more than four 
weeks. The results show that pediatric brain tumors contain neural stem-like cells with 
altered characteristics that may contribute to tumorigenesis. This may have important 
implications for treatment via specific targeting of stem-like cells within brain tumors.  
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Introduction 
Primary malignant central nervous system tumors are the most frequent form of 
solid malignancy in children (Smith et al., 1998). While they are a heterogeneous group 
of tumors, some of the most common histological types are astrocytomas (52%), 
primitive neuroectodermal tumors (PNETs), including medulloblastoma (21%), and high 
grade gliomas (19%) (Sklar, 2002). Despite several advances in therapy, morbidity and 
mortality remain high (MacDonald et al., 2003). 
The cellular origin of pediatric brain tumors remains a mystery whose solution is 
critical for the effective diagnosis, treatment, and basic understanding of brain tumor 
biology. One possibility is that pediatric brain tumors arise by transformation of 
proliferating neural stem cells (Brustle and McKay, 1995; Holland et al., 2000). Neural 
stem cells are defined by their fundamental ability to self-renew and differentiate into 
neurons and glia of the central nervous system (Morrison et al., 1997). There are several 
lines of indirect evidence in support of the possibility that brain tumors arise from stem-
like cells. First, pediatric brain tumors often contain multiple cell types, suggestive of an 
origin from a cell with multilineage potential (Valtz et al., 1991). Second, many pediatric 
brain tumors, particularly PNETs and medulloblastomas, appear to arise from the 
ventricular zone, the region of the brain that houses proliferating progenitors, including 
neural stem cells (Alvarez-Buylla and Garcia-Verdugo, 2002; Koos and Horaczek, 1985; 
Sanai et al., 2004; Sutton et al., 1992). Third, both pediatric brain tumors and neural stem 
cells express nestin, an intermediate filament characteristic of progenitor cells for 
multiple lineages, including astrocytes, neurons, oligodendroglia, ependymal cells, 
melanocytes, and smooth muscle (Almqvist et al., 2002; Rorke et al., 1997; Tohyama et 
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al., 1992). Fourth, pediatric brain tumors often express genes that regulate proliferation 
and self-renewal of normal neural stem cells, such as growth factor receptors and 
components of the Wnt and Sonic hedgehog signaling pathways (Gilbertson et al., 2001; 
Taipale and Beachy, 2001; Wechsler-Reya and Scott, 2001). Mutations in genes that 
normally regulate neural stem cell proliferation are frequently found in pediatric brain 
tumors, suggesting that aberrant proliferation of neural stem cells may underlie 
tumorigenesis. For example, the Pten tumor suppressor gene is often mutated in 
glioblastomas, medulloblastomas and PNETs (Mischel et al., 2003); similarly, the 
epidermal growth factor receptor is amplified or mutated in high grade gliomas 
(Watanabe et al., 1996). Finally, forced expression of oncogenes in neural stem and 
progenitors cells in mice produces tumors that are histologically and genetically similar 
to primary human tumors, demonstrating the capability of transformed neural stem cells 
to produce tumors (Holland et al., 2000).  
 If pediatric brain tumors contain cells with stem cell properties, an important 
question is whether these cells behave like “normal” stem cells or whether individual 
stem cells have abnormal properties that are responsible for the aberrant and persistent 
growth of the tumor (Reya et al., 2001). In models of breast cancer and acute 
myelogenous leukemia, “cancer stem cells” have been isolated and re-passaged into 
experimental animals to form new tumors, providing strong evidence that these cells are 
the root cause of the tumor (Al-Hajj et al., 2003; Bonnet and Dick, 1997).  Such 
individual cells are capable of self-renewal, proliferation and differentiation to create the 
complex, heterogeneous tumor. It is unknown whether pediatric brain tumors contain 
such cancer stem cells, and, if so, whether such cells are derived from neural stem cells. 
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In the current study, we explored the fundamental properties of pediatric brain 
tumors and asked whether they contained progenitor cells with characteristics similar to 
those of neural stem cells. We have isolated and characterized multipotent, self-renewing 
cells from tumor samples, here referred to as “tumor-derived progenitors” which have 
both similarities to and differences from normal neural stem cells. Cells derived from 
pediatric brain tumors were able to produce proliferating neurospheres that could be 
passaged at clonal density and differentiated into cells with defining antigenic 
characteristics of neurons and glia (Reynolds and Weiss, 1992). These neurospheres 
expressed many genes characteristic of neural stem cell-derived spheres. Furthermore, 
like normal neurospheres, tumor derived spheres migrated and continued to proliferate 
when transplanted into neonatal rat brain. Unlike neural stem cells, however, these 
tumor-derived progenitors were more long-lived and often gave rise to abnormal dual-
phenotype cells. Our data suggest that pediatric brain tumors arise from cells with many 
of the characteristics of neural stem cells, but with abnormal ability to propagate and 
differentiate. These studies also raise the possibility that some tumor-derived cells may 
be cancer stem cells with the ability to generate pediatric brain tumors. 
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Materials and Methods 
Tissue Collection and Grading 
Pediatric brain tumors and non-tumor human brain specimens from patients undergoing 
neocortical resections for intractable epilepsy were obtained within 30 minutes of 
surgical resection in accordance with protocols approved by institutional review boards at 
UCLA Medical Center and the California Institute of Technology. The epilepsy surgery 
tissue was taken from the lateral ventricular surface and immediately adjacent tissues. 
Tumors were graded at UCLA Medical Center by the attending neuropathologist in 
accordance with World Health Organization (WHO) established guidelines (Kleihues et 
al., 2002).  
 
Neurosphere Culture 
Tumors and neurosphere cultures were performed as according to the protocol for human 
neurospheres described by Svendsen with some modifications (Svendsen et al., 1998). 
100-500 mm3 pieces of tumor or “normal” brain ventricular tissue were washed in chilled 
sterile phosphate buffered saline (PBS, pH 7.4) with 0.6% glucose. The tissues were 
minced with scissors into small pieces. Pieces were incubated in 0.1% trypsin (Gibco-
Invitrogen), 0.04% DNAase (Sigma type II) in Hank’s balanced salt solution (HBSS) for 
45 minutes at 37°C. The digested tissues were washed three times in 0.04% DNAase in 
HBSS and then triturated successively in the same solution using first a 5 ml pipette 
(Falcon), a1000 µm pipette tip, and then a fire-polished Pasteur pipette. Dissociated cells 
were passed through a 100 µm cell strainer (Falcon), followed by passage through a 70 
µm cell strainer. Cells were seeded at a concentration of 100,000 per ml into tissue 
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culture flasks and grown in proliferation medium containing DMEM-F12 (Gibco 
Invitrogen), penicillin G, streptomycin sulfate, amphotericin B (1:100; Gibco-Invitrogen), 
B27 (1:50; Gibco-Invitrogen), recombinant human fibroblast growth factor (FGF-2, 20 
ng/ml; Peprotech), recombinant human epidermal growth factor (EGF, 20 ng/ml; R&D 
Systems), LIF (20 ng/ml; Chemicon) and heparin (5 µg/ml; Sigma). Fresh FGF-2 and 
EGF were added at the same concentrations twice each week. Spheres were passaged by 
gentle trituration through a fire-polished Pasteur pipette, followed by re-seeding into 
fresh proliferative medium. To create clonal density spheres, moderate density spheres 
(described above) were triturated through a fire-polished Pasteur pipette, and the resulting 
cell suspension was passed through a 40 µm cell strainer to create a single-cell 
suspension (Geschwind et al., 2001). Cell counts were performed, and cells were 
reseeded in 2:3 filtered mouse-neurosphere conditioned medium diluted in proliferation 
medium at a density of 1000 cells per ml.  
 
Immunocytochemistry of Neurospheres 
Immunocytochemistry of neurosphere cultures was performed as previously described 
(Kornblum et al., 1997). Differentiation was induced by plating the neurospheres onto 
coverslips pre-coated with poly-L-lysine (Sigma) in Neurobasal medium (Gibco-
Invitrogen) supplemented with B27 and in the absence of added bFGF or EGF. After 
seven days, the plated neurospheres were fixed in 4% paraformaldehyde and 
immunostained with rabbit anti-nestin (1:200; Chemicon) or rabbit anti-musashi (1:200; 
Chemicon) for neural stem and progenitor cells, mouse anti-TuJ1 (1:500; Berkeley 
Antibodies) or anti-Hu (1:300; Molecular Probes) for neurons, rabbit anti-GFAP (1:500; 
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DAKO) for astrocytes, and anti-O4 (1:40; Chemicon) for oligodendrocytes, followed by 
Alexa flurophore-conjugated secondary antibodies (1:2000 Molecular Probes). In some 
cases, nuclei were counterstained with DAPI. Visualization was performed with 
fluorescence microscopy using a Zeiss Axiophot and images captured with a Zeiss 
Axiocam.  
 
Statistical Analysis 
Total cell counts of clonal neurospheres were performed by counting the number of 
nuclei within the neurospheres incorporating DAPI, as observed under fluorescence 
microscopy. Cell counts are reported as a percentage of total cells expressing nestin, 
TuJ1, and/or GFAP among several clonal neurospheres plated across two to three 
coverslips. Data were analyzed using the paired t-test and presented as the mean ± 
standard error of measurement. Controls consisted of the identical cultures incubated in 
the absence of primary antibodies. 
 
Immunohistochemistry of Whole Tumor Sections 
Formalin-fixed, paraffin-embedded tissue specimens from BT1-3 and BT5 were 
sectioned at 8µm. Sections were mounted on Superfrost Plus slides (Fisher), 
deparaffinized in Histosol (National Diagnostics), and processed for antigen retrieval by 
microwave heating as previously described (Imam et al., 1995). Briefly, the slides were 
placed in a glass jar containing 0.01M sodium citrate buffer, pH 6.0, and heated twice for 
5 minutes each in a microwave oven at the highest power setting. The slides were cooled 
in the jar until they returned to room temperature. The slides were washed in distilled, 
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deionized H2O for 5 minutes, then in PBS, and stained with the appropriate primary and 
secondary antibodies, as described above.  
 
BrdU-Labeling of Neurospheres 
Neurospheres were cultured in proliferative medium containing 2 µM 5-Bromo-2'-
Deoxyuridine (BrdU) for 14 hours. The cells were fixed in 4% phosphate-buffered 
paraformaldehyde solution. Staining with anti-BrdU antibody (Becton-Dickinson) was 
performed according to manufacturer's suggestions and BrdU+ nuclei were observed and 
counted with fluorescence microscopy.  
 
 
Semi-Quantitative RT-PCR 
 
Total RNA was isolated from normal ventricular brain and tumor samples, neurosphere 
cultures, and neurospheres differentiated for 7days by TRIzol (GIBCO BRL), and 1µg of 
RNA from each sample was converted to cDNA by reverse transcriptase, following the 
manufacturer’s protocol (Superscript II, Life Technologies). The amount of cDNA was 
examined by rt-PCR using primers for a glyceraldehyde-3-phosphate-dehydrogenase-
gene (GAPDH) as an internal control from 25 to 33 cycles. After a confirmation of the 
equal amount of cDNA for each sample, the resultant cDNA was subjected to PCR 
analysis using primers specific to genes, listed below. The protocol for the thermal cycler 
was denaturation at 94ºC for 5 min, followed by 36 cycles of 94ºC (30 sec), 60ºC (1 min), 
and 72ºC (1 min), with the reaction terminated by a final 10 min incubation at 72ºC. 
Control experiments were run either without reverse transcriptase or without template 
cDNA to ensure that the results were not due to amplifications of genomic or 
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contaminating DNA. Each reaction mixture was visualized after 2% agarose gel 
electrophoresis for 30 min, and the expression levels of each gene were compared 
between the cDNA samples on a same gel. The intensities of signal were scored as -, ±, 
+, ++, +++ by an independent observer.  
 
Msi1 S 5’gagactgacgcgccccagcc3’ 
Msi1 AS 5’cgcctggtccatgaaagtgacg3’ 
CD133 A 5’ctggggctgctgtttattattctg3’ 
CD133 AS 5’acgccttgtccttggtagtgttg3’ 
Sox2 S 5’accggcggcaaccagaagaacag3’ 
Sox2 AS 5’gcgccgcggccggtatttat3’ 
Melk S 5’cttggatcagaggcagatgtttggag3’ 
Melk AS 5’gttgtaatcttgcatgatccagg3’ 
PSP S 5’ggcggggcagtgcctttcaaa3’ 
PSP AS 5’tgttggctgcgtctcatcaaaacc3’ 
Bmi-1 S 5’ggagaccagcaagtattgtccttttg3’ 
Bmi-1 AS 5’cattgctgctgggcatcgtaag3’ 
 
 
 
 
Transplantation of Neurosphere Cells into Neonatal Rats 
Intracranial transplantation of neurosphere cells into neonatal rat brain was performed 
according to the methods of Uchida et. al. with some modifications (Uchida et al., 2000). 
Animals were treated in accordance with protocols approved by the UCLA Institutional 
Review Board. Neurosphere cells were dissociated with gentle trituration through a fire-
polished Pasteur pipette and the number of live cells determined by Trypan blue 
exclusion. Neonatal (postnatal day 1) rats were anesthetized by placing them on ice for 5-
10 minutes. Once cryoanesthetized, the pups were placed on a stereotactic device and 
injected with 1 µl of cells containing 50,000 cells into the neostriatum. The injected rats 
were kept for 4 weeks before they were examined for human cells.  
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Immunohistochemical Analysis of Transplanted Rat Brain 
Four weeks after transplantation, the injected rats were perfused with 4% 
paraformaldehyde. Brains were removed, post-fixed for 2 hours in 4% paraformaldehyde, 
cryoprotected in 20% sucrose overnight, and serially sectioned at 20 µm on a cryostat. 
Sections were incubated in primary and secondary antibodies as described above. To 
detect human cells in the transplanted brains, sections were stained with a mouse 
monoclonal antibody against human nuclei (1:100; Chemicon).  
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Results 
Primary brain tumors from 22 patients were used in the current studies. The 
tumors included: 10 gliomas including 2 glioblastomas, 6 medulloblastomas, 5 primitive 
neuroectodermal tumors (PNET) and 1 ependymoma.  For detailed analysis of cell fate 
and gene expression, we studied a subgroup of 6 tumors from 5 pediatric patients, aged 5 
months to 6 years, [designated tumors 1-5 (BT1-BT5); Table 1] that were obtained within 
30 minutes of surgical resection for this study. These tumors included a midline 
anaplastic astrocytoma, as defined by the World Health Organization (WHO grade III 
astrocytic tumor; BT1), two cerebellar medulloblastomas (BT2 and BT3), one 
glioblastoma multiforme (WHO grade IV astrocytic tumor; BT4), and one desmoplastic 
medulloblastoma (BT5), distinguished from medulloblastoma by marked neuronal 
differentiation (Kleihues et al., 2002).  
 
Brain tumor cells have the ability to form neurospheres 
 As a first step to test for the presence of stem-like cells in pediatric brain tumors, 
tumors were dissociated into single cells and assayed for their ability to form 
neurospheres using the same methods as described previously for human neural stem 
cells (Svendsen et al., 1998; Uchida et al., 2000). From all 22 primary brain tumors 
studied, this resulted in the production of proliferating neurospheres. Small spheres of 
approximately 4-10 cells in diameter were observed in culture flasks between 3 days and 
1 week after seeding the cells at moderate density (100,000 cells/ml; Fig. 1A). The 
frequency with which dissociated cells formed viable microspheres was very high, as 
each flask contained a far greater number of spheres than did flasks with cells propagated 
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from noncancerous ventricular zone seeded at the same density. Within 2 weeks, most 
spheres had increased their diameters approximately 5 to 10-fold. Cells from a local 
recurrence of one tumor (BT4, glioblastoma multiforme) also gave rise to spheres in 
culture. Neurospheres could be passaged multiple times by mechanical dissociation of 
large spheres and reseeding in fresh proliferative medium every 2-3 weeks. Under these 
circumstances, neurospheres could be maintained for 16 weeks or more. 
We next asked whether tumor-derived progenitors maintained the differentiative 
capacity of neural stem cells. To test this, we examined the types of molecular markers 
expressed by neurospheres grown under both proliferative and differentiating conditions.  
Early-passage spheres maintained in culture for 4 weeks or less were used for further 
characterization. For most tumors, immunocytochemical analysis of undifferentiated 
tumor spheres in proliferation medium revealed many cells expressing the neural 
progenitor marker nestin  (Lendahl et al., 1990)  (Fig. 1B; except BT3) and relatively few 
cells expressing the neuronal marker ßIII tubulin and/or the astrocytic marker GFAP (Fig. 
1C). Tumor-derived neurospheres passaged in culture between 10 and 16 weeks 
maintained these high levels of nestin expression and low levels of ß III-tubulin and 
GFAP expression, similar to typical neurospheres derived from embryonic mammalian 
germinal zones. 
In order to assess differentiation potential, neurospheres were transferred to 
differentiating medium (lacking bFGF and EGF) and were grown for 7 days on an 
adherent substrate. Under these conditions, cell division in the spheres slowed 
dramatically and attached cells appeared to migrate on the substrate.  
Immunocytochemical analysis revealed an increase in the proportion of cells expressing 
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ßIII tubulin and/or GFAP.  Differentiated neurospheres produced numerous cells 
resembling neurons and astrocytes, with many cells extending processes on the substrate 
(Fig. 1D). These results show that pediatric brain tumors contain cells with properties 
similar to those of neural stem cells. These cells have the ability to form neurospheres 
and can differentiate into cells with neuronal and glial characteristics spontaneously at 
low incidence under proliferative conditions and at high incidence when grown under 
differentiative conditions.   
 
Tumor-derived progenitors can be serially recloned  
The above results show that primary tumor cells have the ability to form 
neurospheres. Self-renewal and multipotency are critical features of any stem cells, 
including neural stem cells (Morrison et al., 1997). Accordingly, we next tested whether 
individual cells derived from these neurospheres had the ability to form new 
neurospheres that subsequently differentiated into multiple cell types. To this end, 
primary neurospheres were tested for their ability to form secondary spheres when 
dissociated into single-cell suspensions and reseeded at clonal density (1000 cells/ml) in 
proliferative medium.  Conditions were similar to those used previously to establish 
clonality for primary neurospheres (Groszer et al., 2001). When tumor samples are 
seeded at this density and examined the following day, only individual cells and no 
clusters could be observed, verifying their clonal origin.  In all cases, clonally-derived 
neurospheres were visible within 2-4 weeks after reseeding. This result suggests that 
neurospheres contain individual stem-like cells with the ability to self-renew and form 
neurosphere colonies.  
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Immunocytochemistry was used to compare the molecular markers expressed by 
clonal neurospheres grown under proliferative and differentiation conditions. We first 
examined the expression of two proteins known to be present in a majority of neural stem 
and progenitor cells. Undifferentiated clonal spheres from 4 out of 5 tumors expressed 
nestin in a large percentage of their cells (> 45%) with little variability between clones 
(Figs. 1E and 2A, B, D, E). However, nestin protein expression was undetectable in BT3, 
a medulloblastoma (Fig. 2C). In addition, tumor-derived spheres expressed significant 
immunostaining for musashi-1, a marker of neural stem and progenitor cells (Fig. 1F) 
(Sakakibara et al., 2002). After transfer to differentiating conditions for 7 days, the 
proportion of nestin expressing-cells declined in clonal spheres derived from 3 out of the 
4 tumors (Fig. 2A, B, D) remaining unchanged only in BT5, a desmoplastic 
medulloblastoma (Fig. 2E).  
To understand the differentiative capacity of clonal tumor-derived neurospheres, 
we quantitatively compared the cell types produced by spheres prior to and after 
differentiation using cell type-specific markers. Clonal neurospheres gave rise to cells 
with neuronal and glial properties.  Under differentiation conditions, the majority of 
clones from each tumor gave rise to cells resembling both neurons and glia, with many 
cells per sphere expressing ßIII-tubulin and/or GFAP (Figs. 1G). The average percentage 
of ßIII-tubulin+ cells in clonal spheres increased significantly after transfer to 
differentiation conditions in all tumors except BT5, a desmoplastic medulloblastoma 
(Fig. 2, left panel). The average percentage of GFAP+ cells in clonal spheres increased 
significantly after differentiation in all tumors except BT4, a glioblastoma multiforme 
(Fig. 2, left panel). Differentiated clonal spheres expressed the neuronal HuC/D antigen 
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in similar proportions to their expression of ß III-tubulin (Fig. 1H). In contrast, the 
oligodendrocyte marker O4 could not be detected by immunocytochemistry in clonal or 
high density neurospheres. These results show that tumors contain progenitor cells that 
are multipotent, giving rise to cells with neuronal and glial characteristics. 
Although all tumors gave rise to both neuronal and glial-like cells, the percentage 
varied considerably from one tumor to another (Fig. 2, right panel). BT5 produced 
neurospheres which differentiated into both neurons and glia. The remaining tumors gave 
rise to a mixture of clones, some of which formed multiple cell types and others that 
formed only neuron-like cells. Curiously, BT1 produced some clones that formed neither 
neurons nor astrocytes. It is interesting to note that the lowest proportion of neurospheres 
differentiating into multiple cell types was observed in BT3, the only tumor studied that 
had very low levels of nestin protein (Fig. 2C).  
 
Properties of clonally derived spheres recapitulate characteristics of the parental 
tumors 
 The results described above demonstrate that tumor-derived progenitors are self-
renewing and multipotent. In order to determine whether these findings recapitulate the 
properties of the parental tumors or are simply an artifact of culture, we examined the 
antigenic characteristics of 4 tumors for which we had both neurosphere counts and 
sufficient tumor tissue for further analysis (Fig. 3).  Tumors were stained for nestin, 
GFAP and TuJ1.  Interestingly, the staining patterns demonstrated broad similarities to 
those observed in tumor-derived spheres.  For example, BT1 expressed high levels of 
nestin within the tumor (Fig. 3A) as well as in neurospheres. In addition, many cells in 
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this same tumor expressed either TuJ1or GFAP (Fig. 3E). BT2 (Fig. 3 B, F) also express 
all three markers but at lower levels than BT1, both in the parent tumor and in the 
neurospheres. BT3 had little nestin staining in the tumor (although nestin is obvious in 
the adjacent normal brain; Fig. 3C); this low level of nestin parallels that observed in the 
neurospheres (compare Figs. 2C and 3C). With respect to TuJ1 and GFAP (Fig. 3G), BT3 
had strong reactivity for both, as did the neurospheres (Fig. 2C). BT5 showed good 
correlation between the numbers of TuJ1 and GFAP in both the tumors (Fig. 3H) and 
neurospheres (Fig. 2E); in contrast, nestin expression did correlate well between tumor 
and neurosphere in this one particular case (Fig. 3D and 2E).  Taken together, these data 
indicate that the tumor derived spheres, even after months in culture, differentiate 
similarly to the original tumors from which they were derived in the majority of cases.   
  
Tumor-derived neurospheres express neural stem cell-related genes 
We used semi-quantitative RT-PCR analysis to determine whether neurospheres 
cultured from pediatric brain tumors expressed multiple genes enriched in neural and 
other stem cells, and to compare expression amongst proliferating and differentiating 
tumor progenitors as well as non-propagated tumor. Primers were designed for the 
following human genes: CD133, a cell surface protein expressed on all fetal human 
neural stem cells (Uchida et al., 2000); musashi-1, an RNA binding protein robustly 
expressed by mammalian neural stem and progenitor cells (Kaneko et al., 2000); Sox2, an 
early transcription factor expressed in neural stem cells and the developing neural tube 
(Cai et al., 2002; Zappone et al., 2000); bmi-1, a Polycomb Group gene required for self-
renewal and proliferation of normal and leukemic hematopoietic stem cells (Lessard and 
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Sauvageau, 2003; Park et al., 2003). We also examined the expression of two genes that 
we have identified from mouse neural progenitors by a subtractive microarray screening 
approach: melk, maternal embryonic leucine zipper kinase and PSP, phosphoserine 
phosphatase (Easterday et al., 2003; Geschwind et al., 2001; Terskikh et al., 2001). Both 
of these genes are highly and selectively expressed in murine central nervous system 
germinal zones and are present in both neural progenitors and hematopoietic stem cells.  
All tumors as well as cells derived from the ventricular zone of normal brain had 
detectable gene expression of CD133, Sox2, melk, PSP, and bmi-1 (Table 2). Those 
genes expressed in both tumor-derived and normal neurospheres were also expressed in 
their parental tissues, suggesting that gene expression observed in neurospheres is not an 
artifact of cell culture. We consistently detected expression of Sox2, melk, and bmi-1 
across all whole tumor, normal brain, and undifferentiated neurosphere samples. 
Interestingly, expression of some genes, most noticeably PSP, was reduced or lost in 
spheres, as compared to whole tumor or ventricular zone-containing tissue. This suggests 
that either uncultured tissues expressed these genes at higher levels than their 
neurosphere-initiating cells and their progeny, or that these genes were down-regulated as 
a consequence of cell culture. Neurospheres from BT1 and BT4, both glial tumors of 
different pathological grades, expressed nearly all stem cell-related genes, but BT3 and 
BT5, both medulloblastomas, had significantly lower or absent detectable expression of 
those genes, indicating that cells in glial tumors might have a closer molecular relation to 
neural stem cells. In 11 instances, expression of specific genes in the tumor-derived 
spheres was reduced after growth factor withdrawal, consistent with our prediction that 
tumor-derived progenitors would produce differentiated cells at the expense of 
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multipotent progenitor cells. For example, expression of melk was reduced after 
differentiation in all neurospheres, except those from BT1. In only two instances did 
expression of specific genes increase after differentiation; for example, PSP in BT2 and 
CD133 in BT3.  
The expression of Sox2 by brain tumor-derived progenitors is consistent with 
their being multipotent cells related to neural stem cells. Expression of this transcription 
factor is highly restricted being generally limited to embryonic stem cells (Easterday et 
al., 2003)  and neural progenitors (D'Amour and Gage, 2003; Graham et al., 2003) and 
likely regulates multipotentiality of ES cells (Nichols et al., 1998; Niwa et al., 2000) and 
inhibits differentiation of neural progenitors (Graham et al., 2003). 
Interestingly, all whole tumors and normal brain samples tested expressed high 
levels of bmi-1, a protein thought to be involved in stem cell self-renewal (Lessard and 
Sauvageau, 2003; Park et al., 2003). All tumor-derived neurospheres maintained high 
bmi-1 expression both under proliferative and after differentiative conditions.  In 
contrast, normal neurospheres had significantly less bmi-1 expression, which further 
declined after differentiation.   
 
Tumor-derived neurospheres incorporate into rat brain 
 It has previously been shown that cells derived from normal human neurospheres 
migrate, proliferate and differentiate within multiple sites after transplantation into 
developing rodent brains (Brustle et al., 1998; Uchida et al., 2000). To test whether 
tumor-derived progenitors possess the same abilities, 50,000 dissociated cells from 
neurospheres derived from BT4 at passage 4 were injected into the neostriata of neonatal 
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rats. Using an anti-human nuclear antibody, human cells were found seeding the 
subventricular zone of the lateral ventricle (Fig. 4A), in the corpus callosum (Fig. 4B), 
and at the injection site (Fig. 4C) by four weeks post-injection. Those human cells 
localized to the corpus callosum had elongated nuclei, consistent with the possibility that 
transplanted cells were migrating (Fig. 4B) (Yang et al., 2000). Some human cells in all 
locations expressed the neuronal marker Hu (Fig. 4 A and B) whereas others expressed 
the astrocytic marker GFAP (data not shown). To test whether transplanted tumor-
derived progenitor cells and their progeny continued to proliferate in vivo, they were 
examined for co-expression of the Ki-67 antigen, a nuclear marker of proliferation 
expressed by cells in late G1/S/G2/M phases of the cell cycle (Gerdes et al., 1983). 
Approximately 50% of transplanted cells co-expressed Ki-67, indicating that at least half 
of the tumor-derived progenitors and their derivatives continued to proliferate 4 weeks 
after transplantation into rat brains (Fig. 4C).  
 
Tumor-derived neurospheres have similarities to and differences from normal 
neurospheres 
We compared the properties of tumor-derived neurospheres to those of normal 
neurospheres cultured from the brain tissue of pediatric epilepsy surgery patients with age 
ranges similar to those of the tumor patients studied. For tumor-derived spheres, 
neurospheres could be maintained at moderate to high density for at least 4 months with 
no obvious change in their proliferative properties.  In contrast, normal neurospheres 
grown under identical conditions typically persisted no longer than 1 month in culture.  
This suggests that tumor-derived neurospheres maintain proliferation for much longer 
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time periods than normal neurospheres. Consistent with this possibility, tumor-derived 
spheres demonstrated unusual proliferation even in apparently differentiated cells. We 
observed cells that expressed both ßIII-tubulin and Ki-67, a proliferation-specific nuclear 
antigen, suggesting that cells with the appearance of differentiated neurons were dividing 
(Fig. 5A). Moreover, approximately 50% of ß III-tubulin+ cells incorporated BrdU after a 
14 hour pulse, indicating that a significant proportion of tumor-derived neurons divided 
over a brief time (Fig. 5B).  
A second distinction was noted in the differentiative capacity of normal versus 
tumor-derived neuropheres. Neurospheres from all tumors tested gave rise not only to 
neurons and glia, but also to unusual individual cells that expressed both the neuronal 
marker ßIII-tubulin and the astrocytic marker GFAP (Fig. 2). Such dual-fate cells were 
common and represented a significant fraction of the population. ßIII-tubulin+GFAP+ 
cells often appeared larger than other cells in the same sphere (Fig. 1G, arrows). In two 
tumors, BT1 and BT5, the percentage of ßIII-tubulin+ GFAP + cells exceeded the 
percentage of cells expressing ßIII-tubulin or GFAP alone (Fig. 2). These abnormal cells 
were observed in pediatric brain tumor-derived neurospheres at both moderate and clonal 
density. Previous studies have reported similar abnormal cells derived from adult brain 
tumors (Ignatova et al., 2002). 
These results demonstrate that tumor-derived neurospheres, while sharing many 
features with neurospheres derived from non-neoplastic tissue, also have important 
differences. Both populations contain individual progenitor cells that are multipotent, 
having the ability to form neurospheres comprised of both neurons and glia. However, 
the cancer-derived stem-like cells appear to proliferate at a higher rate and can be 
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maintained in culture for significantly longer than neural stem cells isolated under similar 
conditions. In addition, they frequently undergo abnormal differentiation into dual 
phenotype neuronal/glial cells not seen in normal neuropheres. 
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Discussion  
Recently, it has been recognized that some tumors contain cancer stem cells, a 
rare subpopulation of tumor cells that phenotypically resemble stem cells (Al-Hajj et al., 
2003; Bonnet and Dick, 1997). An intriguing possibility is that these may represent the 
exclusive tumorigenic portion of the cancer.  The discovery of such a population may 
have profound implications for the study and treatment of cancer (Dick, 2003; Reya et 
al., 2001). 
In the present study, we asked whether pediatric brain tumors contain neural 
stem-like cells that may be responsible for the formation of pediatric brain tumors.  Our 
results show that tumor-derived cells indeed have the ability to form neurospheres and 
can be propagated for prolonged times in culture. These results with pediatric brain 
tumors mirror those previously found for adult gliomas, demonstrating that both share the 
ability to produce neurospheres (Ignatova et al., 2002).  We further showed that this 
property is not unique to a single type of tumor, but rather is a general property of all of 
the 22 tumors examined in this study. After transplantation into neonatal rat brains, 
neurosphere cells from one representative tumor seeded the subventricular zone and 
corpus callosum, gave rise to cells with antigenic properties of neurons and glia, and 
continued to proliferate in the brain one month after transplantation.  
To test whether these had properties of stem cells, we demonstrated that, at clonal 
density, cells derived from these neurospheres are capable of self-renewal and are 
multipotent, differentiating into cells resembling neurons and astrocytes. Our results 
show for the first time that the properties of self-renewal are common to all of the 
pediatric brain tumors tested.  Interestingly, the types of progeny arising from 
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neurospheres vary from tumor to tumor and, to some extent, recapitulate the properties of 
their tumor of origin. Further demonstrating the relationship between tumor-derived 
progenitors and neural stem cells, both expressed many of the same genes and proteins.  
Among the characteristics in common between tumor-derived spheres and normal 
neural stem cells is the expression of specific genes, including CD-133, musashi-1, sox-2, 
melk, psp, bmi-1 and nestin. The latter is of particular interest, as it has been clearly 
demonstrated to be expressed by most, if not all, mammalian neural stem and progenitor 
cells.  Only one of the tumors we studied, a medulloblastoma (BT3), failed to express 
nestin in most cells within undifferentiated clonal neurospheres. Interestingly, BT3 was 
the least stem cell-like of all the tumors we tested. It gave rise to the lowest percentage of 
multipotent neurospheres, did not express nestin protein, and failed to express most of the 
stem cell genes in its spheres. It is possible that the cells that formed spheres from BT3 
were not the stem-like cells within the tumor, or that our cell culture conditions changed 
the phenotype of the cells, since the original tumor expressed many of the genes 
characteristic of stem cells. Another key gene is Sox2. This transcription factor is 
exclusively expressed in neural progenitors during mouse development and plays a 
critical role in the maintenance of the neural progenitor state (Graham et al., 2003). 
Interestingly, all tumors and neurospheres tested expressed this transcription factor. In 
addition, tumor derived spheres express other markers that are specifically enriched in 
neural stem cells, such as MELK and PSP (Easterday et al., 2003; Terskikh et al., 2001). 
Although tumor-derived progenitors have many similarities to neural stem cells 
and to each other, it is important to note that differences exist between them and neural 
stem cells as well as between tumor-derived progenitors from different tumors. For 
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example, unlike normal neurospheres, cancer-derived neurospheres undergo aberrant 
proliferation and differentiation. Clonally-derived spheres from an individual pediatric 
brain tumor generally gave rise to similar percentages of neuron- and glial-like cells, 
suggesting that each tumor contained a fundamental type of stem cell.  However, the 
degree of differentiation and types of cells produced differed from tumor to tumor. This 
may reflect a difference in the original stem cell, or simply stochastic differences in how 
the cell responds to environmental influences.   
One surprising finding of our study is that the tumor-derived neurospheres tend to 
differentiate into an array of progeny with the same general profile as the parental tumor.  
Immunohistochemical analysis of the original tumor revealed striking similarities with 
the corresponding neurosphere. For example, BT3 had a high predominance of TuJ1-
positive cells in both the tumor and the tumor-derived neural stem cells, while BT1 and 
BT2 contained a greater mix of neurons and glia.  Importantly, our data demonstrate that 
the presence of diverse cell types in the tumors is not simply a result of the presence of 
“host” cells within the tumor mass, but rather is a property of the tumor itself.  
Our finding that pediatric brain tumors contain neural stem-like cells is consistent 
with the hypotheses that at least some pediatric brain tumors are derived from 
transformed neural stem cells in the central nervous system. It has previously been 
hypothesized that medulloblastomas and PNETs are derived from multipotent progenitor 
cells (Valtz et al., 1991). While supporting that notion, our data also suggest that pediatric 
astrocytomas and high-grade gliomas are derived from either neural stem cells or 
progenitor cells, given that clonal spheres derived from such tumors are multipotent. 
Previous studies have demonstrated that high grade gliomas can form multiple 
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differentiated cell types (Mischel et al., 2003), and that some cells derived from adult 
gliomas in a manner similar to that described here, can form neurospheres with multiple 
differentiated cell types (Ignatova et al., 2002). One possibility is that gliomas are derived 
from a fully committed glial cell that then “de-differentiates” to become multipotent.  In 
this case, while the source of the tumor-forming cell would not be a stem cell, per se, the 
net result would still be that the tumor contained self-renewing, multipotent cells. 
Alternatively, gliomas may be derived from a neural stem cell that is fundamentally the 
same as that which gives rise to PNETs or medulloblastomas.  In the mouse, there is 
strong evidence to indicate that there is a lineage of cells that progresses from primitive 
cells within the neural tube to radial glia to GFAP-expressing “astrocytes” that all retain 
the fundamental properties of neural stem cells: self-renewal and multipotency (Doetsch 
et al., 1999) (Imura et al., 2003). We hypothesize that phenotypically different tumors 
derive from oncogenic transformation of cells at different points along this pathway, but 
retain broad developmental potential and the capacity to self-renew. However, as stated 
above, it is possible that the same result would be obtained if more committed cells re-
attained a stem cell-like state during oncogenesis. 
The mechanism whereby normal neural stem cells become malignant is not clear. 
Our data demonstrate that normal and tumor-derived spheres express the oncogene bmi-
1, with tumor-derived spheres expressing higher levels. This gene has been demonstrated 
to be important for self-renewal of both leukemic and normal hematopoietic stem cells 
(Lessard and Sauvageau, 2003) (Park et al., 2003). It is possible that the high level of 
bmi-1 expression in tumor cells indicates a greater capacity for self-renewing divisions. 
Consistent with this possibility, bmi-1 levels drop in normal neurospheres derived from 
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postnatal brain grown under differentiating conditions. However, bmi-1 levels do not fall 
for tumor-derived progenitors grown under differentiating conditions. Thus, maintenance 
of bmi-1 correlates with prolonged proliferative ability of tumor-derived progenitors. 
Cancer stem cells have been prospectively isolated from acute myelogenous 
leukemia and, more recently, from breast cancer (Bonnet and Dick, 1997) (Al-Hajj et al., 
2003). These cells can be sorted using surface markers expressed by stem cells in normal 
bone marrow or mammary epithelium. The existence of these cells is consistent with the 
possibility that cancer stem cells derive from transformed somatic stem cells. Moreover, 
cancer stem cells share with their non-tumorigenic counterparts the properties of self-
renewal and multipotency. Individual cancer stem cells transplanted into 
immunodeficient NOD-SCID mice have the ability to generate more cancer stem cells as 
well as all of the cell types that are found in the tumor, thereby recapitulating the human 
tumor (Reya et al., 2001).  
While we have shown that tumor-derived progenitors, like normal neural stem 
cells, are able to migrate, proliferate and differentiate when transplanted into developing 
rat brains, it is not yet known if the tumor-derived cells capable of forming neurospheres 
also have the ability to form tumors in an animal model. Given the ability of rats to 
mount an immune response against engrafted human cells, it is not surprising that we did 
not observe tumors in transplanted animals. Future assays for tumor formation will be 
carried out in long-term studies using immunodeficient mice, as previously described 
(Al-Hajj et al., 2003).  
 Although we hypothesize that tumor-derived progenitor cells are, in fact, clonally 
derived from tumor cells, it is formally possible that normal neural stem cells or 
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progenitors may  “contaminate” the tumor mass and thus account for the formation of 
neurospheres. There are two reasons for this concern: first, normal neural stem cells 
residing in the ventricular zone might have been included in the specimens obtained from 
surgical resection of the tumors, many of which were located at or near the midline. 
Second, others have reported that neural stem cells transplanted into rodent brains 
carrying human brain tumor cells have an affinity for tumors and can “track” infiltrating 
tumor cells and disseminate within the tumor bed (Aboody et al., 2000). To address these 
concerns, we compared the proliferation and differentiation of tumor-derived progenitors 
to those of cells derived from age-matched human brain specimens obtained from 
epilepsy surgeries. Quite strikingly, tumor-derived specimens produced far more spheres, 
which proliferated faster, and persisted in culture months longer than those not derived 
from tumors. Only tumor-derived spheres gave rise to individual cells expressing both 
neuronal and glial markers. Moreover, only tumor-derived spheres maintained high 
expression levels of bmi-1 before and after differentiation.   
Knowledge of the developmental origin of pediatric brain tumors has important 
implications for therapy. We have explored the intriguing possibility that these tumors 
may be derived from progenitor cells with stem-cell like properties.  Indeed the results 
show that cells derived from pediatric brain tumors form neurospheres that can be serially 
recloned and contain self-renewing stem cells.  These stem cells are multipotent, giving 
rise to both neurons and glia in similar proportions to their tumors of origin.  Although 
they resemble normal neural stem cells, they also exhibit important differences including 
an increased proliferative rate, persistently elevated bmi-1 expression, and the tendency 
to form abnormal dual phenotype cells.  This approach can be used to elucidate 
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tumorigenic pathways, as well as to evaluate candidate anti-tumor therapies. These have 
the potential to identify improved diagnostic markers and therapeutic targets for pediatric 
brain tumors. Demonstration that tumor-derived progenitors are cancer stem cells for 
pediatric brain tumors suggests that therapies for treating pediatric brain tumors should 
include methods for targeting and elimination of the stem cell population. 
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Table 1 
Tumor and patient characteristics 
 
 
Tumor Patient Age Diagnosis Site of Tumor 
BT1 5y Anaplastic astrocytoma Midline hypothalamus
BT2 5mo Medulloblastoma Cerebellum 
BT3 6y Medulloblastoma Cerebellum 
BT4 6y Glioblastoma multiforme Temporal lobe 
BT5 15 mo Desmoplastic medulloblastoma Cerebellum 
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Table 2 
Gene expression analysis 
 
Whole Tumors BT1 BT2 BT3 BT4 BT5 Normal 
CD133 ND ± ++ + ++ + 
Msi1 ND ++ - + ++ ++ 
Sox2 ND ND ++ ++ + + 
Melk ND +++ + +++ ++ +++ 
PSP ND +++ +++ ++ ++ ++ 
Bmi-1 ND ND ND +++ +++ +++ 
Spheres Undiff.       
CD133 + ± - + - - 
Msi1 ++ - - ++ ± ++ 
Sox2 ++ ++ ND ++ ± + 
Melk +++ ++ + +++ + +++ 
PSP +++ + - ++ - - 
Bmi-1 +++ +++ ND +++ ND + 
Spheres Diff.       
CD133 + - ++ - - - 
Msi1 ++ - ND - ± ++ 
Sox2 ++ ++ ± - - ± 
Melk +++ + - ++ ± + 
PSP - +++ - - - - 
Bmi-1 +++ +++ ND +++ +++ ± 
 
Table 2:  Semi-quantitative RT-PCR of pediatric brain tumors (BT1-5) and normal human 
brain analyzed for expression of stem cell markers.  ND = not determined; - = no signal; ± = 
minor signal; + = weak signal; ++ = moderate signal; +++ = strong signal. 
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Figure 1 
 
 
 
Fig. 1: Tumor-derived progenitors form neurospheres in culture that give rise to both neuronal 
and glial cells.  Neurospheres from one tumor, BT1, were cultured at medium (A-D) and clonal (E-H) 
densities. (A) A typical primary neurosphere is round in morphology and contains numerous 
birefringent cells when viewed under phase contrast optics. (B and C) Undifferentiated primary 
neurospheres expressed high levels of nestin protein (B, green) and low levels of (C) βIII-tubulin (red) 
and GFAP (green). (D) After 7 days of exposure to differentiation conditions, primary neurospheres 
significantly increased numbers of cells expressing β−III-tubulin and GFAP, and produced cells 
extending processes onto the substrate. (E) Undifferentiated clonal neurosphere cells have high levels 
of nestin expression. (F) Undifferentiated clonal neurospheres expressed the neural stem cell marker 
musashi-1 (green) in nearly every cell.   (G) A neurosphere derived from a single cell that, under 
differentiation conditions, formed cells expressing β−III-tubulin (red) which is characteristic of 
neurons and GFAP (green), which is characteristic of astrocytes. Some cells expressed both markers. 
(H) Differentiated clonal neurospheres produced cells expressing the neuronal marker Hu (green) in 
similar proportions to β−III-tubulin. Some nuclei were counterstained with DAPI (F and H, blue). 
Scale bar in H = 30 µm in A, G, and H, 60 µm in B-F.   
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Figure 2 
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Fig. 2:  Neurospheres derived from multiple types of tumors give rise to cells 
expressing neuronal and glial markers in various proportions. Left panel: average 
count of cells expressing nestin, TuJ1 alone, GFAP alone, or both markers in clonal 
neurospheres (NS) from BT1-5 (A-E) prior to (white) and after (black) differentiation. 
Right panel: Fates of clonal neurospheres (NS) after differentiation. Markers used are 
TuJ1 for neurons (N) and GFAP for astrocytes (A).  
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Figure 3 
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Fig. 3: Immunohistochemical characteristics of original tumor samples. Paraffin-
embedded sections were labeled with antibodies to nestin (green; A-D), TuJ1 (red; E-H) 
to recognize neurons or GFAP (green; E-H) to recognize glia. Area denoted by asterisk 
in C and F delineates normal brain tissue adjacent to the tumor. Scale bar in H = 60 µm 
in A-H.   
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Figure 4 
 
 
 
 
Fig. 4: Neurospheres derived from BT4 tumor become incorporated into the 
ventricular zone and corpus callosum after grafting to the brain of neonatal rats. 
(A) A coronal section showing the grafted cells stained for a human nuclear antigen 
(green) are in the ventricular zone.  Some express the neuronal marker Hu (red).  (B) A 
coronal section through the corpus callosum shows elongated human cells (green) with 
the morphology of migratory cells.  Some of these also express Hu (red; arrow).  (C)  A 
coronal section through the injection site in the ventral portion of the brain shows that 
many (~50%) of the injected cells (green) also express the proliferation marker Ki-67 
(red).  Arrows indicate some of the double-labeled cells.  Sections were counterstained 
with DAPI to identify all nuclei in A and B. Scale bar in C = 90 µm in A and B, 45 µm in 
C. 
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Figure 5 
 
 
 
 
Fig. 5: Tumor-derived neurospheres give rise to neurons that proliferate aberrantly. 
(A) In this clonal neurosphere derived from the BT4 tumor, some cells co-expressed 
β−III-tubulin (red) as well as the proliferation marker Ki-67 (green). Nuclei were 
counterstained with DAPI (blue). (B) 50% of cells that expressed β−III-tubulin 
incorporated BrdU (green) after a 14 hour pulse, indicating that they have undergone cell 
division. Scale bar in B = 15 µm in A and B.  
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Introduction 
 In vertebrate embryos, neural crest cells arise at the border between the 
prospective epidermis and prospective neural plate, and migrate away from the neural 
tube to give rise to a wide variety of derivates including craniofacial bone and cartilage, 
melanocytes, neurons and glia of the peripheral nervous system, and smooth muscle 
(LaBonne and Bronner-Fraser, 1999). 
 In chicken embryos, neural crest cell migration occurs between E2 and E3, from 
stages 13-22 (Bronner-Fraser, 1986). In response to the observation that the number of 
sensory neurons and Schwann cells in dorsal root ganglia increases long after neural crest 
migration has ended (Carr and Simpson, 1978), Eric Frank’s group injected the vital dye 
DiI into the central canal of stage 25-26 (E4.5 to E5) chick embryo neural tubes to 
determine if the neural tube is a source of those cells (Sharma et al., 1995a). They 
observed a wave of late-migrating neural crest cells originating in the dorsal root entry 
zone, exiting the neural tube through the dorsal roots, and populating the dorsal root 
ganglia. This finding was confirmed by transplanting isochronically and isotopically 
quail neural tubes into stage 25-26 chick embryo hosts and following the fates of the 
quail cells by staining chimeric embryos with the quail-specific nuclear antibody QCPN 
(Sharma et al., 1995a).  
 In order to locate the source of the late-migrating neural crest cells from the late-
stage avian spinal cords, the same group injected large numbers of dissociated, 
uncultured, dorsal and ventral spinal cord cells from stage 18 (E2.5) and stage 27 (E5.5) 
quail embryos into the neural crest migratory pathway (cranial half of forelimb-level 
somites) of stage 16-20 (E2.5) chick embryo hosts (Korade and Frank, 1996). After 1-10 
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days, host embryos were harvested, and sections were stained for QCPN, neuron-specific 
TuJ1, and quail neuron-specific QN to detect migration and differentiation of the injected 
quail spinal cord cells. Korade and colleagues found that while both young and old dorsal 
spinal cord cells could produce neural crest derivatives such as sensory and sympathetic 
neurons, Schwann cells, and melanocytes, only young (E2.5) ventral spinal cord cells 
could produce all of those derivatives; old (E5.5) ventral cells were restricted to several 
crest derivates with the specific exceptions of sensory and sympathetic neurons (Korade 
and Frank, 1996). Moreover, old ventral spinal cord cells migrated significantly less than 
their dorsal or younger ventral counterparts (Korade and Frank, 1996).  
The aforementioned findings prompt the question of what the source is for these 
late-persisting cells that have the potential to generate neural crest derivatives as a 
population. Are these cells existing as or derived from multipotent stem or progenitor 
cells in the neural tube that persist well after neural crest emigration has traditionally 
ceased? The results of several studies support this possibility. In mouse (Serbedzija et al., 
1992; Serbedzija et al., 1994), frog (Collazo et al., 1993), and chick (Bronner-Fraser and 
Fraser, 1988; Bronner-Fraser and Fraser, 1989) embryos, single-cell lineage analyses of 
dorsal neural tube have shown that individual precursor cells in the neural tube can form 
both neural tube and neural crest derivatives. Further evidence for the existence of neural 
tube progenitors with neural crest potential comes from the isolation in monolayer cell 
culture of neuroepithelial (NEP) stem cells from rodent neural tubes that, on a clonal 
level, can generate derivatives both of the central nervous system and the neural crest 
(Mujtaba et al., 1998). Moreover, Morrison et al. have prospectively isolated neural crest 
stem cells from embryonic rat peripheral nerve at E14.5 using flow cytometry (Morrison 
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et al., 1999). These cells can generate neural crest-specific neurons and glia in clonal 
culture and after back-transplantation into chick embryos (Morrison et al., 1999). 
Similarly, self-renewing neural crest stem cells have been recently isolated from both 
embryonic (Bixby et al., 2002) and adult (Bixby et al., 2002) gut from rodents. Taken 
together, these findings suggest that multipotent, self-renewing cells that possess the 
ability to generate neural crest derivatives can persist in both older embryos and adults, 
and in some cases can be cultured as undifferentiated cells.  
In this study, we explored the question of whether the potential for cells from 
spinal cords of older avian embryos to generate neural crest derivatives originates in 
multipotent stem or progenitor cells that persist in the neural tube after the cessation of 
neural crest emigration. By culturing spinal cord cells from avian embryos at different 
stages in development as neurospheres, using culture methods similar to those used for 
neural stem and progenitor cells from the embryonic and adult mammalian nervous 
system, we asked how late into development such progenitors persist, how their 
developmental potentials change as a function of embryonic age, whether they can be 
cultured long-term in an undifferentiated state, and whether they can generate multiple 
neural crest derivatives at both bulk and clonal densities both in vivo and in vitro. We 
show that dissociated cells from E3, E5, E7, and E10 quail neural tubes can be cultured 
as neurospheres at both bulk and clonal densities. When cultured in the presence of 
fibroblast growth factor (FGF) and epidermal growth factor (EGF), these cells cultured as 
neurospheres fail to generate melanocytes, a neural crest derivative, after one month in 
culture, but cells derived from E5 embryos produce melanocytes in vivo and in vitro after 
two or more months in culture. Our data suggest that the late-emigrating wave of neural 
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crest derivatives from avian embryos arise from progenitor cells that persist in the neural 
tube.  
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Materials and Methods 
Isolation of Avian Spinal Cord Cells 
Fertile quail or hen’s eggs obtained from local farms were incubated for 3 to 10 
days at 38°C to obtain embryos at appropriate stages for these experiments (Hamburger 
and Hamilton, 1992).  Spinal cords were dissected and dissociated according to methods 
previously reported, with some modifications (Korade and Frank, 1996). Briefly, quail 
embryos of the appropriate stages were dissected, removing the head, tail below the 
hindlimb, and all tissue extraneous to the neural tube. Trunk segments were incubated in 
dispase solution first for 15 minutes on ice, then at 37°C in a humidified incubator for 15 
minutes. Dispase was removed and trunk segments were recovered for 15 minutes on ice 
in Hank’s Balanced Salt Solution (HBSS; Invitrogen) containing 0.2% Bovine Serum 
Albumin (BSA; Sigma). Trunk segments were triturated gently with a Pasteur pipet to 
separate neural tubes from non-neural tissue. Neural tubes were then incubated in 0.1 
mg/mL Ca/Mg-free trypsin solution (Invitrogen) diluted in HBSS for 10 minutes at room 
temperature. Trypsin was removed and neural tubes were recovered in HBSS containing 
0.2% BSA. Neural tubes were triturated with a flame-polished Pasteur pipet to dissociate 
the cells. The single-cell suspensions were centrifuged for 5 minutes at 3500 RPM and 
cell pellets were resuspended in neurosphere culture medium.  
 
Neurosphere Culture 
         Neurosphere cultures were performed as previously reported, with some 
modifications (Hemmati et al., 2003). Cell pellets resulting from a single-cell suspension 
of dissociated quail neural tubes were resuspended in Neurobasal medium (Invitrogen) 
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supplemented with basic fibroblast growth factor (20 ng/ml), epidermal growth factor (20 
ng/ml), and B27 supplement (Invitrogen; 1x) at a density of 100,000 cells/ml. Clonal 
cultures were plated at a density of 1,000 cells/ml in quail neurosphere conditioned 
medium.  
 
Transplantation of Neurospheres into Chick Embryos 
         Both whole and dissociated quail neurosphere cells were concentrated in 
neurosphere culture medium by brief centrifugation in a tabletop microcentrifuge at low 
speed. Concentrated cells were backfilled into fine glass needles and injected into for 
forelimb-level somites of E2.5 (stage 18) white leghorn chick embryos.  
 
Immunohistochemical Analysis of Transplanted Chick Embryos 
         Between 1 and 72 hours after transplantation, embryos were harvested from the 
eggs and all membranes dissected from them. Brachial segments were dissected from the 
embryos and retained for further analysis. For immunohistochemistry, brachial segments 
were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) at 4°C for 1 h 
and embedded in gelatin for cryosectioning. Immunostaining was performed as described 
previously (Hemmati et al., 2003) using anti-rabbit, -mouse or -sheep secondary 
antibodies coupled to Alexa fluor 488 (green) and 594 (red; Molecular Probes). Nuclei 
were visualized with DAPI (Molecular Probes).   
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Results 
Embryonic Quail Spinal Cord Cells Generate Neurons, Glia and HNK-1+ Cells 
When Transplanted into Chick Embryos 
 To determine whether dissociated cells from embryonic quail spinal cord could 
engraft chick embryos after transplantation into the neural crest migratory pathway of 
chick, cells from E3.5 quail embryos were transplanted into the forelimb-level somites of 
stage 18 chick embryos as previously performed (Korade and Frank, 1996). Transplanted 
embryos were harvested and fixed at 1 and 48 hours after injection of cells and 
incubation of eggs. They were sectioned through the area of transplantation and stained 
for QCPN (a marker of quail nuclei), HNK-1 (a marker for neural crest and other 
embryonic cell types), and Hu (a protein expressed by early neurons). In embryos fixed 
immediately after transplantation, quail cells were confined to the area of transplantation, 
adjacent to the neural tube (Fig. 1A). No donor cells could be seen ventral to the area of 
injection. Moreover, immediately after transplantation, very few (< 1%) of donor cells 
expressed Hu or HNK-1, suggesting that donor cells at those stages had not yet 
differentiated to express those differentiation markers (Fig. 1A). In embryos fixed 48 
hours after transplantation, far larger numbers of cells were localized ventral to the site of 
injection (Fig. 1B) as well as around the transplantation site (Fig. 1C). While a relatively 
higher proportion of ventrally-localized quail cells expressed HNK-1 but not Hu (Fig. 
1B), donor cells localized adjacent to the neural tube expressed either HNK-1 or Hu in 
significant proportions (Fig. 1C). Some quail cells in both dorsal and ventral aspects of 
the older transplanted embryos had elongated nuclei, consistent with Schwann cells (data 
not shown). These data confirm the migratory capacity of neural tube-derived cells 
 89
previously reported (Korade and Frank, 1996) and suggest that dorsally-localized cells 
preferentially produce neurons.  
 
Embryonic Quail Spinal Cord Cells Can Be Cultured as Neurospheres 
 To examine the stem or progenitor cell properties of cells from embryonic spinal 
cords, dissociated cells from quail neural tubes at varying embryonic stages were assayed 
for their ability to form neurospheres using the same methods as previously described for 
human neural stem cells from both fetal and tumor tissue (Hemmati et al., 2003; Uchida 
et al., 2000). Large numbers of small spheres (~5-10 cells in diameter) were observed 
within 24 or 48 hours in flasks seeded with 100,000 cells/ml of dissociated cells from 
quail embryos harvested at E3 (Fig. 2A), E5 (Fig. 2B), E7 (Fig. 2C), and E10 (Fig. 2D). 
Within 1 week, most spheres had increased their diameters ~5- to 10-fold. Neurospheres 
could be passaged multiple times by mechanical dissociation of large spheres and 
reseeding in fresh proliferative medium every 1-2 weeks and could be maintained in 
culture for 10 weeks or more. These neurospheres could also be dissociated into single-
cell suspensions and reseeded at clonal density (1,000 cells/ml; data not shown). 
Furthermore, the growth properties of these neurospheres were independent of their 
embryonic age of origin.  
This high rate of neurosphere growth was seen only when culturing the cells in 
Neurobasal medium under serum-free conditions, supplemented with recombinant FGF 
and EGF. Fewer spheres and lower overall growth rate were appreciated when culturing 
cells in DMEM-F12 under otherwise identical conditions (data not shown). Dissociated 
neural tube cells from embryos at any stage failed to produce neurospheres when cultured 
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in the presence of fetal bovine serum, chick embryo extract, or both (data not shown). 
These data suggest that neural tube cells from quail embryos respond similarly to those 
from mammalian sources, raising the possibility that avian cells likewise contain 
multipotent neural stem and/or progenitor cells.  
 
Quail Neurosphere Cells Can Generate Melanocytes In Vitro and In Vivo 
To assess the capacity of stem or progenitor cells in embryonic quail spinal cord 
to generate neural crest derivatives, we examined the production of melanocytes from 
spinal cord-derived neurospheres over time both in culture and after transplantation into 
the neural crest migratory pathway of chick embryos. 3 weeks after seeding into 
proliferative medium, pigmented cells, presumed to be melanocytes, were rare in 
neurospheres cultured from E3, E5, and E7 embryos (Fig. 2A-C) and altogether absent 
from E10 embryos (Fig. 2D), suggesting that neurosphere culture conditions allow spinal 
cord progenitors to remain undifferentiated and that between E7 and E10, melanocyte-
producing cells change in a way that hinders their ability to produce melanocytes at this 
stage. After 8 weeks under the same culture conditions, nearly all neurospheres derived 
from E7 embryos at bulk (Fig. 3A) density and many spheres grown at clonal density 
(data not shown) were composed of a significant proportion of melanocytes, estimated to 
be range from 10 to 40% of the total number of cells within each sphere. Neurospheres 
from E3, E7 and E10 embryos were not examined at this time point in culture.  
To determine whether neural tube-derived neurosphere cells can migrate and 
differentiate within embryos similar to neural crest cells, small numbers of neurospheres 
from E5 quail embryos were injected into the forelimb level somites of stage 18 chick 
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embryos. Embryos were collected 48 hours after transplantation, sectioned, and examined 
for the presence of melanocytes. In some embryos, pigmented cells derived from quail 
donor cells were found localized to regions distant to the site of transplantation, such as 
the gut (Fig. 3B and 3C), suggesting that melanocytes or their precursor cells within 
neurospheres have the ability to migrate in vivo.  
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Discussion 
 In the present study, we asked whether spinal cords from avian embryos at stages 
older than the time of cessation of traditional neural crest emigration contain stem or 
progenitor cells that might contribute some or all of the neural crest derivatives shown 
previously to arise from the late-emigrating population of neural crest cells (Korade and 
Frank, 1996; Sharma et al., 1995a). Our results show that quail spinal cords from E3 
through E10 embryos contain cells capable of being cultured as neurospheres, which can 
be propagated in culture for at least 8 weeks at both bulk and clonal densities. We show 
that during early passages of these neurospheres, they fail to produce significant numbers 
of melanocytes, a neural crest derivative, but that spheres cultured from at least one 
embryonic stage (E5) are capable of generating many melanocytes after 8 week of culture 
under identical conditions. This temporal change suggests that melanocytes precursor 
cells within the neurospheres might be maintained in an undifferentiated state for some 
time, but that this inhibition of differentiation decreases with time. Moreover, we 
demonstrate that neurosphere cells from E5 quail neural tubes can become localized to 
the host gut and produce melanocytes 48 hours after transplantation into the neural crest 
migratory pathway of chick embryos.  
 The ability of cells within avian embryonic neural tubes to respond similar to 
mammalian neural stem and progenitor cells when cultured in classical neurosphere 
culture medium suggests that avian neural tubes might contain neural precursor cells with 
similar properties of self-renewal and multilineage differentiation. To begin to assess 
whether such progenitor cells exist, we showed that after long-term (8+ week) culture, 
neurosphere cells from at least one embryonic stage in culture cold generate substantial 
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numbers of melanocytes, a neural crest derivative. We also demonstrated that avian 
neurosphere cells can migrate and exist as melanocytes after transplantation into chick 
embryo hosts. It remains to be seen whether, at a bulk or clonal level, these same 
neurosphere cells can generate other neural crest or central nervous system cell types as 
well, including neurons, glia, and/or smooth muscle.  
 Might the neurosphere-generating cells we have isolated via cell culture from 
embryonic avian neural tubes be stem or progenitor cells that ultimately produce the late-
emigrating wave of neural crest cells and their derivatives (Korade and Frank, 1996; 
Sharma et al., 1995a) ?  Recently, another group has reported an intriguing finding in 
mouse embryos that neural crest-derived boundary cap cells, that form clusters at surface 
of the neural tube, at entry and exit points of peripheral nerve roots, are responsible for 
generating neurons and glia that until now were attributed to a late-emigrating wave of 
neural crest cells from the neural tube (Mora and Gerald, 2004). While doing so, they do 
not show that boundary cap cells contribute to any melanocytes lineage cells, which 
others have attributed to cells with neural crest potential residing in the dorsal neural tube 
(Mosher and Morrison, 2004; Sharma et al., 1995b). This suggests the interesting 
possibility that two different cell types might play critical but unique roles in generating 
the repertoire of cells traditionally classified as “late-migrating” neural crest derivatives: 
boundary cap cells might contribute the neuronal and glial components, while progenitors 
in the neural tube might exclusively contribute the melanocytes component (Mosher and 
Morrison, 2004).  
 Several avenues of study must be pursued in order to determine whether the 
neural tube of older-stage embryos contains multipotent neural crest progenitor cells or 
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only melanocytes-restricted precursors that can be cultured as neurospheres. First, clonal 
neurospheres must be differentiated in vitro, stained for various markers of neurons and 
glia, and examined for the presence of melanocytes. Failure to produce neurons and glia, 
while maintaining melanocytic potential, would support the latter model. Clonal spheres 
should also be transplanted into chick embryos to explore their cells’ potentials within the 
embryonic microenvironment. Similar experiments should be conducted using 
neurospheres cultured from E3, E7, and E10 quail embryos, in addition to the E5 stage 
described in the present study. Finally, these neurosphere cells must be serially recloned 
to establish whether they have self-renewal capacity. These and other experiments are 
presently underway and promise to shed important light on the elusive cell of origin for 
late-migrating melanocytes. Future studies should also examine the possibility that 
transformation of melanocyte precursor cells leads to the development of malignant 
melanoma or other skin cancers (Nakano et al., 2004). 
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Figure 1 
 
 
 
 
 
Fig. 1: Dissociated E3.5 quail neural tube cells migrate, proliferate, and produce 
neurons and glia when transplanted into the neural crest migratory pathway of 
Stage 18 chick embryos.  Large numbers of uncultured, dissociated cells from E3.5 quail 
embryos were injected into forelimb level somites of Stage 18 chick embryos. (A) Small 
cluster of quail cells expressing QCPN (red) but which contains few HNK-1+ (green) 
cells and no neurons (Hu; blue) confined to the injection site lateral to the neural tube 
(NT) in host embryos fixed immediately after transplantation.  (B and C) Relatively large 
numbers of quail cells, some expressing HNK-1 or Hu, localized to the ventral (B) and 
dorsal (C) aspects of transplanted chick embryos fixed 48 hours after transplantation.  
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Figure 2 
 
Fig. 2: Dissociated quail neural tube cells from varying embryonic stages can be 
cultured for weeks as neurospheres with minimal differentiation. Cells from E3 (A), 
E5 (B), E7 (C), and E10 (D) quail embryos form neurospheres that, after 3 weeks in 
culture, contain relatively few pigmented cells, presumably melanocytes. Pigmented cells 
are confined to E3-E7 embryo-derived neurospheres (A-C), but are not seen in E10-
derived spheres (D) 3 weeks after onset of culture.  
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Figure 3 
 
Fig. 3: After 2 months in culture, neurosphere cells from E5 quail neural tubes 
generate melanocytes in vitro and after transplantation into chick embryo hosts. (A) 
Neurospheres derived from E5 quail neural tubes generate melanocytes in large 
proportions in nearly every sphere in culture at 8 weeks in culture. (B & C) 2 days after 
transplantation of 8 week-old neurospheres from E5 quail embryos into the forelimb-
level somites of stage 18 chick embryos, melanocytes can be seen in the foregut of 
transplanted embryos (arrows; magnified inset from B in C).  
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STEM AND PROGENITOR CELLS IN DEVELOPMENT 
 
 Stem cells are, at a minimum, defined as cells that possess the capacities to both 
self-renew and give rise to multiple differentiated progeny (Morrison et al., 1997). The 
term “progenitor” is used as a general term to describe any dividing cell that can generate 
differentiated progeny, irrespective of its ability to self-renew. Given these properties, 
stem and progenitor cells have long intrigued scientists, for they play important 
developmental roles and have the potential to replace cells lost or damaged through 
disease processes (Lagasse et al., 2001).  
Stem cells have been isolated and characterized from different tissues from a 
variety of organisms, in both embryos and adults, including blood-forming hematopoietic 
stem cells from fetal liver (Morrison et al., 1995) or adult bone marrow (Spangrude et al., 
1988), and the neural crest (Morrison et al., 1999). Thus far, only hematopoietic stem 
cells are routinely used therapeutically in humans, though many promising stem cell 
therapies are on the horizon (Lagasse et al., 2001; Meyer et al., 2006; Moore and 
Lemischka, 2006). Moreover, the recent explosion is stem and progenitor cell research 
has led to the identification of genes and molecular pathways critical for the regulation of 
self-renew and differentiation of stem and progenitor cells from a variety of normal and 
malignant tissues (Moore and Lemischka, 2006). The scientific and clinical significance 
of some of these genes and pathways in the nervous system is discussed later in this 
chapter.  
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IDENTITY AND PROPERTIES OF NEURAL STEM AND PROGENITOR CELLS 
 
 Though it was originally believed for some time that the central and peripheral 
nervous system were unable to generate new neurons during adulthood, evidence of 
continued neurogenesis in the adult pointed to a long-lived neural progenitor cell 
(D'Amour and Gage, 2003).  A series of studies over the last several year demonstrated 
that neurogenesis does indeed occur in the adult mammalian brains, especially at the 
midline and hippocampal areas, from a pool of progenitor cells (Alvarez-Buylla and 
Garcia-Verdugo, 2002). Isolation of stem-like cells from the embryonic central nervous 
system, including the basal forebrain (Reynolds et al., 1992; Temple, 1989), 
hippocampus (Johe et al., 1996), cerebral cortex (Davis and Temple, 1994), spinal cord 
(Kalyani et al., 1997; Kalyani et al., 1998), and the peripheral nervous system (Stemple 
and Anderson, 1992) as well as evidence for multipotent, stem-like progenitors in vivo 
(Leber and Sanes, 1991; Sanes, 1989; Walsh and Cepko, 1993) suggested that stem and 
progenitor cells are important components of the developing nervous system. More recent 
evidence for continued presence of stem cells in the adult in areas not previously 
considered to be neurogenic, such as the spinal cord (Weiss et al., 1996) and cortex 
(Gould et al., 1999; Marmur et al., 1998), suggests that stem and progenitor cells are also 
an important feature of the adult nervous system.  
Reynolds and Weiss demonstrated that neurogenesis in the central nervous system 
is owed to a population of neural stem cells, that can self-renew, generate neurons, 
astrocytes, and oligodendrocytes, and be cultured as floating spherical aggregates known 
as neurospheres (Reynolds and Weiss, 1992). Very elegant studies in the mouse 
demonstrated that neural stem cells are exclusively GFAP-expressing astrocytes located 
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in the subventricular zone (SVZ), lining the walls of the ventricles in the central nervous 
system (Doetsch et al., 1999; Imura et al., 2003; Suslov et al., 2000). More recently, it has 
been shown that in adult human brain, some SVZ astrocytes can also behave like neural 
stem cells, yet active neurogenesis from those progenitors was not proven (Sanai et al., 
2004). In this study, we report that we have cultured neural crest progenitor cells at clonal 
density from quail embryos at various stages of development (E3-E10). We have found in 
preliminary studies that the capacity of these cells to generate melanocytes diminishes 
with embryonic age, and disappears altogether by E10.  
 Gene expression studies have recently shed light on the characteristics of neural 
stem and progenitor cells from various sources. Several groups, for example, have 
reported that neural stem cells share common expression of a subset of genes with other 
stem cells, including hematopoietic stem cells and embryonic stem cells (Burns and Zon, 
2002; Easterday et al., 2003; Geschwind et al., 2001; Ivanova et al., 2002; Ramalho-
Santos et al., 2002). Genes found to be critically important in regulating the self-renewal 
and/or differentiation of neural stem or progenitor cells include PTEN (Groszer et al., 
2006; Groszer et al., 2001), MELK (Nakano et al., 2005), bmi-1 (Molofsky et al., 2003), 
PBK/TOPK (Dougherty et al., 2005), epidermal growth factor receptor (EGFR) 
(Kornblum et al., 1998; Reynolds et al., 1992), and Wnt pathway members (Chenn and 
Walsh, 2002). These genetic similarities among stem and progenitor cells must be 
examined in further detail, as they undoubtedly contain valuable clues regarding the 
molecular mechanisms responsible for the fundamental properties of stem cells.  
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RELATIONSHIP BETWEEN CANCER AND STEM CELLS IN THE NERVOUS 
SYSTEM 
 
 
 In recent years, many groups have been interested in investigating the similarities 
between cancer cells and stem cells (Iwashita et al., 2003; Reya et al., 2001), particularly 
in leukemia (Bonnet and Dick, 1997), breast cancer (Al-Hajj et al., 2003), and brain 
tumors (Galli et al., 2004; Hemmati et al., 2003; Ignatova et al., 2002; Kondo et al., 2004; 
Singh et al., 2003; Singh et al., 2004). The fact that both cancer cells as a population and 
stem cells share the abilities to self-renew and differentiate into multiple phenotypes is 
likely not purely coincidental; rather, they likely share common molecular mechanisms 
that are responsible for their fundamental properties. Further, it is possible that stem or 
progenitor cells (or, more specifically, their critical genetic regulators) are targets for 
malignant transformation, since they are already equipped with the cellular machinery 
required for self-renewal and proliferation (and, in some cases, migration and invasion) 
that most somatic cells do not ordinarily possess (Hemmati et al., 2003; Sanai et al., 
2005; Singh et al., 2004).  
In this study, we report that midline human pediatric brain tumors each contain a 
unique population of multipotent, self-renewing progenitor cells that, when differentiated 
in culture at a clonal level, consistently recapitulate the cellular characteristics of the 
primary tumor from which they are derived (Chapter 2 and Hemmati et al., 2003). While 
brain tumor-derived progenitor cells vary in their developmental potentials from one 
patient to another, there is very low interclonal variability in clonal progenitors derived 
from each tumor, suggesting a common origin for those progenitor cells. Tumor-derived 
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progenitor cells proliferate and differentiate aberrantly in vitro, producing neurons that 
continue to incorporate BrdU and express the proliferation antigen Ki-67, as well as cells 
that coexpress neuronal and glial markers. We report that tumor-derived progenitor cells 
can migrate, proliferate, and differentiate for at least one month after transplantation into 
brains of immunocompromised rodents.  
Brain tumor-derived progenitor cells express many genes traditionally associated 
with neural stem and progenitor cells, including nestin, musashi-1, bmi-1, melk, Sox2, 
CD133, and bmi-1. Our study found that strikingly, even after differentiation, tumor-
derived progenitors maintain high levels of expression of bmi-1, which helps to positively 
regulate self-renewal of multiple types of stem and progenitor cells (Lessard and 
Sauvageau, 2003; Molofsky et al., 2003; Park et al., 2003), whereas normal human neural 
progenitor cells express bmi-1 at significantly lower or undetectable levels. This finding 
raises the possibility that bmi-1 overexpression is involved in maintaining the extensive 
self-renewal capacity of tumor-derived progenitors and, possibly, that of the tumor as a 
whole. This scenario has recently been addressed by another group for medulloblastoma, 
a common pediatric brain tumor (Leung et al., 2004). Moreover, bmi-1 has been shown to 
play an important role in the transformation of hematopoietic progenitor cells into 
leukemic progenitor cells (Lessard and Sauvageau, 2003).  
 Other groups have recently published similar findings from primary adult glial 
tumors (Galli et al., 2004; Ignatova et al., 2002), cultured glial tumor cell lines (Kondo et 
al., 2004), and pediatric brain tumors (Singh et al., 2003). Dirks and colleagues have 
positively sorted for the human neural stem cell surface marker CD133 (Uchida et al., 
2000) to prospectively identify similar neurosphere-forming cells from pediatric brain 
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tumors (Singh et al., 2003). Later, this same group tested the tumor-initiating capacity of 
these CD133-expressing cells by transplanting CD133+  and CD133- cells into the brains 
of immunodeficient nonobese diabetic/severe combined immunodeficiency mice (Singh 
et al., 2004). In their study, only the CD133+ brain tumor fraction contained cells that 
were capable of tumor initiation in xenografts. Injection of as few as 100 CD133+ cells 
produced a tumor that was serially transplantable and was a phenocopy of the patient’s 
original tumor, whereas injection of 105 CD133- cells produced engraftment but did not 
cause a tumor (Singh et al., 2004). This set of experiments gave strong support to the 
cancer stem cell hypothesis as the basis for brain tumor development (Dirks, 2005).  
Another research group has recently shown that large numbers of cultured 
neurosphere cells from adult glioblastoma multiforme can form glioblastoma-like tumors 
with high efficiency after transplantation into immunodeficient mice, and that those 
tumors can yield tumor-forming neurospheres after serial propagation in vivo (Galli et al., 
2004). Taken together, these studies, along with ours, suggest that brain tumor growth is 
initiated and driven by a rare subpopulation of cancer stem or progenitor cells (Nakano 
and Kornblum, 2006).  
 There is also mounting evidence that some peripheral nervous system tumors or 
melanomas might be derived from transformation of neural crest stem cells or their 
committed progenitor cells (Fang et al., 2005; Mora and Gerald, 2004). Fang and 
colleagues have recently shown that CD20-expressing cells cultured from human 
melanoma samples as floating spheres self-renew, give rise to multiple neural crest 
derivatives in culture, and forum tumors in vivo (Fang et al., 2005). Similar experimental 
 105
approaches should be applied to prospectively identify, purify, and evaluate candidate 
cell types from other tumors as cancer stem cells for neural crest lineage tumors.  
 
 
FUTURE EXPERIMENTS 
 
 Our studies, as well as those of other groups, have generated as many questions as 
they have answered. Several critical questions remain to be answered, and we propose the 
following lines of investigation in guiding future experiments in this field: 
  
What are some other markers of brain tumor stem cells?  
Further research into and therapeutic exploitation of cancer stem cells for brain 
tumors requires the prospective identification of a cell that, on a clonal level, can self-
renew and regenerate its parental tumor in vivo. As discussed above, to answer this 
question will require purification of candidate cells using flow cytometry and 
transplantation into NOD-SCID or SCID-beige mice, which do not possess the residual 
non-specific immune responses that have traditionally biased and plagued tumor 
xenograft studies that have used SCID or nude mice as transplant recipients. Though 
those mouse strains are technically immunodeficient, the residual activity of natural killer 
cells and macrophages in those mice might be sufficient to cause rejection of small 
numbers of transplanted human cells, thereby confounding negative results from these 
experiments.  
Most groups, including ours, have identified stem-like cells from cancer using in 
vitro cell culture selection, without cell purification using cell surface markers (Galli et 
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al., 2004; Hemmati et al., 2003; Ignatova et al., 2002). Until now, only one group has 
reported the ability to prospectively enrich for cancer stem cells from primary brain 
tumors in an in vivo xenografts assay in immunodeficient mice (Singh et al., 2004). 
Unfortunately, positive selection for CD133 enriches, but does not purify for cancer stem 
cells in human brain tumors. The fact that 100 or more CD133+ had to be injected by 
Singh and colleagues into mice for tumors to form suggests that the tumor initiating 
fraction comprises a small percentage of CD133-expressing cells, at best. For this reason, 
additional cell-surface markers of brain tumor stem cells must be identified, for purposes 
of positive or negative selection, which would enable further enrichment or purification 
of cancer stem cells from brain tumors. Others in our group are actively engaged in this 
effort.  
 
What are the genetic and epigenetic similarities and differences between tumor-derived 
progenitors or brain cancer stem cells and normal neural stem and progenitor cells and 
whole tumors? 
 A more thorough understanding of gene expression similarities between tumor-
derived cells and normal neural progenitor cells will yield insights into the potential 
lineal relationship between cancer cells and stem cells, whereas gene expression 
differences will highlight potential molecular mechanisms involved in or responsible for 
malignant transformation. This study should be carried out as a cDNA microarray or gene 
chip-based comparison of cDNAs from uncultured progenitor cells freshly purified from 
primary brain tumor or normal brain specimens. A recently published microarray-based 
gene expression analysis of many medulloblastoma samples reported that gene 
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expression patterns predict clinical outcome (Pomeroy et al., 2002). Another recent study 
reported that proteome-based clustering in human gliomas significantly correlated with 
patient survival (Iwadate et al., 2004). We have already begun preliminary experiments to 
this effect, including microarray-based studies of microRNA (oncomir) expression in 
brain tumor-derived progenitors and normal neural progenitor cells (Esquela-Kerscher 
and Slack, 2006).  
 
 
What are the functions of candidate oncogenes in tumorigenic potential or 
transformation of brain tumor-derived progenitors or cancer stem cells? 
 This question elaborates on the previous question by elucidating the roles of genes 
such as melk and bmi-1 in the transformation of neural progenitor cells and maintenance 
of self-renewal and multipotency of tumor-derived progenitor cells. Both overexpression 
and gene knockdown studies should be performed, using both uncultured and cultured 
progenitor cells and cell lines derived from primary brain tumor or normal brain 
specimens. In vitro neurosphere-forming, self-renewal and differentiation assays should 
be combined with in vivo tumor-formation assays in immunodeficient mice in order to 
understand the function of these genes in the tumor formation process at the progenitor 
level.  
We have already commenced some of these studies using melk, PTEN, and 
EGFR-VIII. The expression of the latter two genes in human gliomas has recently been 
shown to have strong clinical significance, as it can guide treatment decisions using 
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EGFR kinase inhibitors erlotinib or gefitinib (Friedman and Bigner, 2005; Mellinghoff et 
al., 2005). 
 
 
THERAPEUTIC IMPLICATIONS 
 
 Exploitation of these findings for the development of improved brain tumor-
specific therapies is no longer a fantasy, and will require careful and deliberate 
investigation. Several new classes of tumor-specific drugs have recently become 
approved for treatment of non-CNS tumors, most of which block the functions of protein 
kinases, but through varying mechanisms of action (Noble et al., 2004). Each of these 
new drugs targets a specific molecular pathway that has previously been shown to be 
important in either the original transformation event or the maintenance of tumor 
proliferation. We and others hope to exploit some of the aforementioned molecular 
pathways active in brain tumor-derived progenitor cells to develop new and customized 
therapeutics for brain tumor patients.  
Gleevec (imatinib), a small molecule drug that inhibits the product of the Bcr-Abl 
translocation that is responsible for the transformation of hematopoietic progenitor cells 
into leukemic stem cells for chronic mylogenous leukemia, is a notable example of a 
new-generation targeted cancer therapy (Noble et al., 2004). Evidence has shown much 
of the anti-cancer activity of Gleevec in chronic mylogenous leukemia can be attributed 
to its activity against leukemic cancer stem cells (Galmozzi et al., 2006). Gleevec also 
inhibits the c-kit receptor tyrosine kinase, as well as the PDGF receptor tyrosine kinase, 
which is expressed on the surface of normal human neural stem cells and brain tumor 
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stem cells (Reardon et al., 2005). A recently-completed Phase II clinical trial of Gleevec 
in patients with recurrent glioblastoma multiforme discovered that the treatment is well-
tolerated and associated with durable antitumor activity in those patients (Reardon et al., 
2005). It remains to be seen whether Gleevec’s activity against malignant gliomas 
parallels its action against leukemia by acting through the cancer stem cell.  
Iressa (gefitinib) and Tarceva (erlotinib) are small-molecule inhibitors that bind 
the intracellular tyrosine kinsase domain of the epidermal growth factor receptor (EGFR) 
and were originally designed to treat (and are FDA approved for) metastatic non-small 
cell lung cancer and pancreatic cancer (Noble et al., 2004). These drugs are highly 
effective against the tumors that they target, and do so with minimal side effects due to 
their molecular specificity. EGFR, which is expressed by both normal and tumor-derived 
neural stem cells, is known to be frequently amplified, overexpressed, or mutated in 
glioblastomas (Dancey and Freidlin, 2003; Smith et al., 2001), but only 10 to 20 percent 
of patients exhibited a response to EGFR kinase inhibitors in recent clinical trials (Prados 
et al., 2006; Rich et al., 2004). Glioblastomas often express EGFRvIII, a constitutively 
active genomic deletion variant of EGFR (Frederick et al., 2000; Wong et al., 1992) that 
strongly activates the PI3 kinase signaling pathway, leading to tumor cell survival, 
motility, and proliferation (Choe et al., 2003). This persistent PI3 kinase signaling is 
thought to cause “pathway addition;” addicted tumor cells die after disruption of the 
pathway (Weinstein, 2002). Bianco and colleagues hypothesized that EGFRvIII would 
sensitize tumors to EGFR kinase inhibitors, whereas PTEN loss would impair the 
response to such inhibitors (Bianco et al., 2003). In a recent clinical study, Mischel and 
colleagues found a strong association between the coexpression of EGFRvIII and PTEN 
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in glioblastoma cells and responsiveness to EGFR kinase inhibitors (Mellinghoff et al., 
2005). This finding of glioblastomas with specific genetic and phenotypic profiles that 
respond to EGFR kinase inhibitors is an important first step rational, tumor-specific 
therapy for malignant brain tumors (Friedman and Bigner, 2005). Recent evidence from 
our group suggests that the PTEN and EGFRvIII mutations in brain tumors function at 
the level of cancer stem cells (data not shown).  
The aforementioned clinical studies support the concept that targeting specific 
mutations and molecular pathways active in tumor stem and progenitor cells is effective 
in treating cancer. Since similar genetic mechanisms regulate the survival and 
development of normal stem and progenitor cells (Bonnet and Dick, 1997; Hemmati et 
al., 2003; Pardal et al., 2003), it is necessary to examine whether drugs that target cancer 
stem cell pathways also inhibit the growth or survival of normal stem cells. A recent 
study by Morrison and colleagues identified different self-renewal mechanisms for 
maintaining pools of leukemic stem cells and normal hematopoietic stem cells (Yilmaz et 
al., 2006). Conditional deletion of the PTEN tumor suppressor gene in adult 
hematopoietic stem cells led to transplantable leukemias within weeks. PTEN deletion 
also promoted proliferation of hematopoietic stem cells, eventually depleting the 
hematopoietic stem cells, and preventing the hematopoietic stem cells from stably 
reconstituting lethally irradiated mice. This illustrated a contrast between normal and 
leukemic stem cells, in that normal hematopoietic stem cells, but not leukemic stem cells, 
required PTEN for self-renewal. These effects were mediated in large part by mTOR, as 
they were inhibited by rapamycin, which targets the mTOR protein. This work is the first 
clear illustration that mechanistic differences between normal stem cells and cancer stem 
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cells can be targeted to deplete cancer stem cells without damaging normal stem cells 
(Rossi and Weissman, 2006).  
 Several steps must be taken in order to develop effective brain tumor-specific 
therapies. First, appropriate drug targets must be discovered and evaluated. As discussed 
above, cDNA microarray screens, coupled with in vitro and in vivo functional studies of 
candidate gene function, will likely yield interesting targets for drug action. Some 
candidate drug targets that might arise from our work with brain tumor-derived 
progenitors include the PTEN tumor suppressor gene, melk, bmi-1,PSP, and PBK/TOPK.  
 Second, candidate drugs need to be evaluated for efficacy in preclinical trials 
using purified tumor-derived progenitors or brain cancer stem cells, as well as NOD-
SCID mouse xenograft models. Current methods of screening candidate drugs in vitro 
rely on the responsiveness of tumor cell lines, some of which have been in serum-
containing culture for many years or decades, to determine whether those drugs will 
graduate to a more complex level of preclinical testing. It is possible that some agents 
that would otherwise be effective against primary tumor-derived progenitor cells fall 
through the cracks during this screening process because they are tested against tumor 
cell lines that no longer resemble tumors found in patients and might not contain 
progenitor cells that are responsible for growth of the tumor in vivo. The recent study by 
Vescovi and colleagues highlights the fact that a popular glioblastoma cell line (U87-
MG) fails to generate glioblastoma-like tumors after transplantation in vivo (Galli et al., 
2004). The pharmaceutical industry has many compounds in its warehouses that can be 
rescreened using primary progenitor cultures.   
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 The characterization of neural progenitor cells from both normal and malignant 
human brain has yielded interesting insights into both normal development of the nervous 
system and the molecular and cellular mechanisms that might be involved in 
tumorigenesis. In the coming years, further investigation will hopefully answer even 
more questions about the origins of brain tumors and create a knowledge base the might 
eventually lead to the development of improved methods to prevent, diagnose, and treat 
cancers of the nervous system.  
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